{
  "experiment_id": "77585995cbd116b8198abe82eb31cabc",
  "task_name": "narrowing_of_broad_synonyms",
  "task_hash": "9dc5c284f909400a12e111d9ec8ba4e5",
  "model_id": "openai/gpt-5.1",
  "system_instructions": "You are a metadata curation assistant. Your task is to help improve and correct metadata \naccording to the specific instructions provided for each task. Be precise, accurate, and \nfollow the guidelines carefully.\n",
  "temperature": 0.0,
  "thinking": false,
  "tools": [],
  "timestamp": "2025-11-19T20:23:49.532988",
  "task_result": {
    "task_name": "narrowing_of_broad_synonyms",
    "num_samples": 10,
    "results": [
      {
        "sample_index": 0,
        "input": {
          "diagnosis": "Neurofibromatosis",
          "assay": "DNA sequencing",
          "tumorType": "Neurofibroma"
        },
        "response": {
          "success": true,
          "content": "{\n  \"diagnosis\": \"Neurofibromatosis type 1\",\n  \"assay\": \"targeted sequencing\",\n  \"tumorType\": \"Neurofibroma\"\n}",
          "model_id": "openai/gpt-5.1",
          "usage": {
            "inputTokens": 2404,
            "outputTokens": 602,
            "totalTokens": 3006
          },
          "attempt": 1,
          "raw_response": {
            "id": "gen-1763583703-y9PaJPkdgvfFfPcq8DXc",
            "provider": "OpenAI",
            "model": "openai/gpt-5.1",
            "object": "chat.completion",
            "created": 1763583703,
            "choices": [
              {
                "logprobs": null,
                "finish_reason": "stop",
                "native_finish_reason": "completed",
                "index": 0,
                "message": {
                  "role": "assistant",
                  "content": "{\n  \"diagnosis\": \"Neurofibromatosis type 1\",\n  \"assay\": \"targeted sequencing\",\n  \"tumorType\": \"Neurofibroma\"\n}",
                  "refusal": null,
                  "reasoning": "**Choosing sequencing type**\n\nI\u2019m considering the absence of context, and I think \"targeted sequencing\" is the best choice since it\u2019s the least assumption-y. Any DNA sequencing that focuses on specific genes is technically 'targeted.' If they\u2019d sequenced the whole exome or genome, they would probably clarify that, so \"DNA sequencing\" likely refers to targeted genes. Thus, I believe \"targeted sequencing\" is the fitting term to use. I\u2019ll return the corrected JSON now.",
                  "reasoning_details": [
                    {
                      "format": "openai-responses-v1",
                      "index": 0,
                      "type": "reasoning.summary",
                      "summary": "**Choosing sequencing type**\n\nI\u2019m considering the absence of context, and I think \"targeted sequencing\" is the best choice since it\u2019s the least assumption-y. Any DNA sequencing that focuses on specific genes is technically 'targeted.' If they\u2019d sequenced the whole exome or genome, they would probably clarify that, so \"DNA sequencing\" likely refers to targeted genes. Thus, I believe \"targeted sequencing\" is the fitting term to use. I\u2019ll return the corrected JSON now."
                    },
                    {
                      "id": "rs_094360a738c44d8e01691e26d7a968819588a24d2f29fcb784",
                      "format": "openai-responses-v1",
                      "index": 0,
                      "type": "reasoning.encrypted",
                      "data": "gAAAAABpHibgDWu_yi7QOuLQ2bMKI5yHTxohc6dNP_RIZvNNfFlEpC0Lp8Pqrd9jj8Y-173Tu3FNLzUgMx-EAzv46faXP5OUQ9aOEO-vWtc1GkQdC-QdHggNNrs6HPVFjYDOczo7hf6YxUR5JSZZs1JkH15COvwbbggI9bbQSbDiEtDbrgtwFY8hiHiSpdjt3UAAHjBlAPeDhBVkPHKvePNErMSqPf2gBJpbxH77DLk0QeBGsM3Pe7CzB9ZFx-Iox109qGRqaFjAceEHukebRtHZfMpRokG6K5b40XvZ31u7aHHRce5-AqqQUuuSzulncaO1_9GpPRB0SvfQqUixaxzhVzboQM024hJm-p388vGYBmUfIAztJ_6IV2XgcpKjCn76kaH2Wgt3N7biarZiolIFt4eJnHVoFbOFvnyiu_8TlZ5MnA8Pmv0CUU12oM0TZglwy6xWwZ6E3552ApOp81YL-xyjUvpm38PrTlbeDjH9ZVBl0VYt-4o-cOlX4HeJJ5BOFx3oYEvFOBQPgB10YYv9ucjkp67v4hZIhpKO5b1PcTyknqDaITIrw2MfPgoGKs2Ew2NGXrUABhbjXUt9Te3477oWJrwY2TSdW_o6ZEXy4vVSOdRS9dUv7Ne2yIGmyxETGPDaQY99Xys_Q9PeEP6gij2LbToY-U00-fy8s7rbKfN_pJV5QafcW17wDU1ys_aRZKhxIXj1ogAGibADaxr_XxBR9nI9JIJ3TvHRzaCDAdutp66SHhUjGKiTrSPDkuJxTHCj7gqaHNSdzs66D4xlPAndrtdjrfErK5KIVGRR71OOt-cDEoLyFF0JNoDQlj70G7q2CFVeUPnNYKx2vSqi9YUsnCXXLWPIkBCiHBY7Wz5DJZS7aySKCszapb1Iin9BAfg31XjzxboLKRdntTczjGlvb8y7lMHNJ8_3wVgC9VhNQDMxFZgFSS1G92oGvJFJxx5-vKZBaXuknm1yM8l3yo6svUYP2nR1B-y43Ro8W3VMn7jsk8XmIggdxVG9bIbaGuOi53o18f_Z9PqJ1qAmgDu__PL95l9oDWMxVY_07JwpURfYVy9f4QzGl7aWD9gsJfrqUGRtIwp_jjuVURDVDRd1jxKnkLhlbfsMr_utG7MhUItmle4qW2l__S9pwMTqzgSAXPsJGhAOz9jlDFJt5-fngkQ_JA6rNvRrb-te4h5LdZf5ddxEE8w8I15swmN4UapLfpzRwPRTE1K0JI1tyhLNmEMVO3QG59O_Q0y9g3vFefvkyinP0jZlwC3mBqa7reWj-ooU-w9soaWroImH8Rxuu1HUeEsKtayHT1J2lwYmozmb7A_fK8Pt1ex8REK1bUEYLbMm3hODLQoTlP0G-RnoOnnv15LYFMuWpYdY388zpxeJke0ll6AFHOanunh2Iw3iyL8erPpSpCRZBlII6U6yMTRHZbHKC6ie0AQaHSuIVr3rFntX9P72QDDUAJ1_8qN9tFRd3u19lCRGEWu8VpkXFgc8Mqa1brrGprD_mx7rvu38LF-K5SYjuoZNwh2nwdnzJ76zdb1BQdYB3p87Jon_rtDwr-IjxR6I4puxe3x_kU5w_y4EDtlftObOHc_SfUIWHGaduuVj4FH1ZiKS-S7lKp-wU7T4K_1CBj5BTHWXOUz7W_l77q8-RK393a02IsbDaSndgwYjuDXhAwiuBjOn-MqZaiqn7EQxzU3z8BZR6D1Dz55VqDjfhm9lVXp7Wiu7FW047myZqV-CrxYId-H31w54_u2t24fmKBRq9uaLrQoJ-D2t7zl2f1gC2nH5PIovqnoFUo74oF9ITbRPrfSoqTCaiwv0jygqepmb-Mue7ePWVQLw_-hhtmQMTc_YHDMcCU-DZMMfR1FVKXwpwHjRC2_e9PXxpddBId_loj_VmLp7K-hgmK7s9SVpMb2dgIgqxTanP5969ashe21IIsOzPu4n6jY1ou6S-PnYd7PDAqFtzMLwPnM36_HFvNbF7hezoSBbSUSbRMuLIAAr_BQSGofAFMipny9166g_jhVQQPAkkbfNxMVZqmPFbi4kOe39ENmyJvjGuVszM-Qndd4t_TEgIs2BQ8j7QIdLKh8TzU73zeK8rkzKXeL9oat1OHr9EKvAU9F-Wxjo32JItK3n6cfAxvGnbxTRcpGpEc1nr3K0rhM2IB4k9P6FeJqQHVWNQ-uEoS575O9tigFqwcuJF0Nz94c4RBwp8iFD2guYdv0zZm1mCtn7d8MqwbMFMpGGM4lm0VfHI7c1oo4MbpmM4iFOf7uF64GScsH-3VW8QjcqZeu7GIck-xfch38FKZ-Q2te4J9xnWByJa1ioOXoV9HfyQdSDpk-3iRo0NV1-VBRehGdPE8LCJBXEl7bw2U0OKJIpO5SPpl9yYWXc9NKQIs5pP2_xSigm6mOuZGjD6lXcKxDloX2XAimUX09_o4E1xNb_nvoK_R4MAX5-zG99WwYw4XC7EtLoBb-SUJ8-wViPDtnAZJgETGStBnXZyiDzrTr1qDDKbulTDH5OGLeNGm3Gr9XxfxcbBmqyThX9QMYCMkUYCjSlLYyPZ7tcw_3fE4o0B4R7pseKo8JvGhwg0EDstmk4IcNeRjnglUbuGBV122wDJmbA91uhuGvKzGzUfCyQ6lbsHdmN6qh2OLk--11NNvsRg7E3oo26NVcZzcEHprO6f3CJSxt4RiF_S5H1HqoPtmshQiv23j5Mi7MEaV7P4nYDPWJQp52YFS6zAfiYV6o8F_s7WSlwqz2kixa64YyxmOINyCiffMPlva0mev7Krn-j0KwnJYCth4n47x4lQ-wFBvLgslkmOoZI-6EOOJdcNz7wJrO5GQVil2n--SM8o1dMUbqDTULTBlMdxVjxcS5YgY8oUL553HdZVwvMN-1kzUMxVWCmv7eJPVGYtl2fs4AbaTq4xB1ryuVR2BdRv8Swm2LliCeU3oFYNa-d5nCVGF1K_2ax4dGWi09uEnPwPA1Rw9jrnjYuF5TvJ8VmO7k_zhOunuXE7-xdAlIF3l7k_1FY7owj8PBEGOFvlwejNiO8f2jzi73XrfM44kVv-hHfZWjoLXq1FsHL6mJ2056hd9JSq2T2PqLxtDdXtVXLaGwNrnsDFWPELNWqha5HyBKzRiIzh5xgECKMCOkGB_YhKQgGDdguWDO8EhHuxKGWvIeweZvMXVGBFrXeoPzLDpeLzCXU0ApcXsB1nDi7a792AXkbQKL2pvpxPFnHP_voKsktzpZpImhhJhjTblXWbs0TIBzn_Af5zxhT7C6qyExttLSfmWoWJ6AL3BC7oMJO9Yi1ZsGCaYfweHwY7S0nl6PPSW1T89o_DXXuvEol0cWgYhAogpKaL_nku1_yf_N3zKqY7WSiTFVK7ng41Ir3VB8V_1DPDRxAK33EujB31zEjOYqjRSet61qiuTU8tEewHMbuQRueIoyG1LTKMpuA8mtnyNh8woJLgu0ZDjUKCmVUD4apjdJE3agXlD9y44AE0YoZhFDvi-6a1mZ5hDNPDR2DRfF4Ie6ZLh52vKxFqCNkYhUPGLRwxVZPDRA8WEdrivSQngJQ82aNVNWjKYCfmhNxQqunwiOHjP0Z-z3g3iM6DkkGhmHGoi00YdORFlNA1S9Gigllzwaizeuk-isRrxDWYkpnTE48jHzKk_6URhvzmrM7opQmBctKKcvRmtV_-I5qiMwOPrY9r849TqxcaB71FzCFmsoAoL5JvRADTNa2_wwQiuOud1qzbQZzbyRObbJUKb8GqR49Xm8ZwbHh3ppaUhvnPTxx2HeGb1whZ1To7_2z79sbMWlpEY3YXOZYDDHkSHB6vwpOg9ZFjWtez3ddg_3xvuCGCXtALElSybIgr73UDfI_5nBXg4iikcO7eO7w47xp1EglsXT-A1f5YtkMM3NpJTcynxo0qLMnpoTeIABq5SdRhnJNAXSBjmZZpRwu6ERsXc95Z8ZBWLXpXFoxq1FDWrVeI0ka92qz8tp-EtOkDYarNQHyI316vuaVdyG1TG-ajicyvM9OBGCg5ymS3bkQwYmW9JzCP5abiWSbr3YxIQWRW7lQf7je9Tx0lpBCaD-vS5VD26NL6nmemq9yznD8pDEYtCLge9_e-LsUW6crEOpUGApSmdAlNl4B2Q=="
                    }
                  ]
                }
              }
            ],
            "usage": {
              "prompt_tokens": 2404,
              "completion_tokens": 602,
              "total_tokens": 3006,
              "completion_tokens_details": {
                "reasoning_tokens": 556
              }
            }
          }
        },
        "score": 0.3333333333333333,
        "ground_truth": {
          "diagnosis": "Neurofibromatosis type 1",
          "assay": "whole exome sequencing",
          "tumorType": "Plexiform Neurofibroma"
        },
        "token_usage": {
          "input_tokens": 2404,
          "output_tokens": 602,
          "total_tokens": 3006
        },
        "tool_calls": [],
        "tool_execution_history": []
      },
      {
        "sample_index": 1,
        "input": {
          "diagnosis": "NF",
          "assay": "exome sequencing",
          "tumorType": "sarcoma"
        },
        "response": {
          "success": true,
          "content": "{\n  \"diagnosis\": \"Neurofibromatosis type 1\",\n  \"assay\": \"whole exome sequencing\",\n  \"tumorType\": \"Sarcoma\"\n}",
          "model_id": "openai/gpt-5.1",
          "usage": {
            "inputTokens": 2398,
            "outputTokens": 161,
            "totalTokens": 2559
          },
          "attempt": 1,
          "raw_response": {
            "id": "gen-1763583712-jSBvBUqN3mqUkCojKOEm",
            "provider": "OpenAI",
            "model": "openai/gpt-5.1",
            "object": "chat.completion",
            "created": 1763583712,
            "choices": [
              {
                "logprobs": null,
                "finish_reason": "stop",
                "native_finish_reason": "completed",
                "index": 0,
                "message": {
                  "role": "assistant",
                  "content": "{\n  \"diagnosis\": \"Neurofibromatosis type 1\",\n  \"assay\": \"whole exome sequencing\",\n  \"tumorType\": \"Sarcoma\"\n}",
                  "refusal": null,
                  "reasoning": "**Narrowing diagnosis**\n\nI need to narrow down the diagnosis of \"NF,\" which is likely \"Neurofibromatosis type 1\" or possibly NF2-related schwannomatosis. NF can be ambiguous, especially since there are different types. The most common is NF1, so I will choose that as the most likely.\n\nFor the assay, \"exome sequencing\" matches with \"whole exome sequencing.\" The tumor type is \"sarcoma,\" and the enum correctly has \"Sarcoma\" with a capital S. I'll return that in JSON format.",
                  "reasoning_details": [
                    {
                      "format": "openai-responses-v1",
                      "index": 0,
                      "type": "reasoning.summary",
                      "summary": "**Narrowing diagnosis**\n\nI need to narrow down the diagnosis of \"NF,\" which is likely \"Neurofibromatosis type 1\" or possibly NF2-related schwannomatosis. NF can be ambiguous, especially since there are different types. The most common is NF1, so I will choose that as the most likely.\n\nFor the assay, \"exome sequencing\" matches with \"whole exome sequencing.\" The tumor type is \"sarcoma,\" and the enum correctly has \"Sarcoma\" with a capital S. I'll return that in JSON format."
                    },
                    {
                      "id": "rs_067a8f19936acede01691e26e18c448195b76a517818d9030f",
                      "format": "openai-responses-v1",
                      "index": 0,
                      "type": "reasoning.encrypted",
                      "data": "gAAAAABpHibk8X8HD9RCzdc9G-QHla9WfL6TwK8Ix0fkoJWjddWK4W4rPloXuB1pwtE7--koOmrNbthyRhE_j6R2P4e5knlR79LGyM25R75JO0Pxws9bVnu9y3Ye7BN51etvHsm1ks1poW9ILT-igeq6Wf_rVwYIAVd1lMCBDPLTG5p06UoGIUJaK6u9ON6H_K43G4sOH4o4ME1o7OAutKTPm9auQqYZJvabCJUFAH1ixWZAibq7AVK6-hjopxD_X8STnLAnz5FswrlXYibR3WEW2z4LF8G5RNuRX3ooMU0L2EI7pfkLqy7bq8GjnnXSGQDWtDO5JSkYssLm-j75VzSPjdfcHS_cGKASxwAVp8eLiad0YSs5qcb6oeVCMDFcXqBbC12V4wdx0Lw9rP0hQU4eBFh6bFR1hnkhtsrKLAzDp0A7SBoY7r7rZzkXvB8hITTXdtn8W5ETV_xm3pD6cwYWJ2bhjkcOxKrQyqIMM4yqaSSwZgzQqSQi5ASSaGI39AX-Zr_i0Kvzahn49sPzIA_xFJ6p1vfq6AwmeeHGsnlqPHzWcIPOSWerDLIvsVlz8ti5jLWJgTJwRzDauL0sDAkUYQ9ANTEX8rCogHmX8pWxjCX67nfKUSQrDb9J8NZ2kcfJrYnL0D_HLYpXxkiHZPuTOAB6aA3IJc-VP0sfwbBXvlfL030FcjvedcWAjNeaZrP1J3pnI3Foz-WA2V_gQPY0PcEAztfIbTgld2dFI4y_2Bf_xlJl8OjiECKvVZCkfc2Y34ZT4JneGXy-4nzpu6A-N9gJaCuagBFjoz21iPDy69J55QMKxPV3rdPaWHq3T0W9NFA3W9o8bceKEqLoRc8LoTmvYkeWJdY018hNRRIKJ8ea4-Itvx7u50ASiV20dqUlPbuxGfo9tlxy0hOiyOHLYvm3qvZv6kDf1lvhVFvco_b80dZaenLa_n250WPJ7lW9sx4cW1pZ7pnU3pDOyMJUDVglLQ62pmCDsakSixn_-kuX4hKzSkZqCAILoAOgOL-pG4dz2JlYplWR1ccO1IQduFnOnbNvoJ38O_kEgXSNvrjNfq5QvxiWHrURtLP5Ob2SZswA1gHscA6C3_MrEMvMxDpBpi7j0NzGMHTojJGh6N-nBV64v8egQ38rMupCXhAelX8evfxDdspmhiUG86DFwdrjpuHbAA8j5-ukaPpur_PLMVMgTdxPnvyP59rA7wp0fjG4W5wdQ7AnxQ6-qVn1B18I3ADFC_aSuELZjEyPDf3k0le2slWu1gsZJkil6VluAWYrwTI-3769rftVpPt2wkMaKFgU76lqWmOLg9JqMZ0GQeVRz1Gl9uIgtpnJGUcnT5DdnPthkiQHx7ft9TVha_elKLo8bVaDsAmVsfxAcWxzZ-9xCOgw-D3YRtNC-sp_YFIpwEK9"
                    }
                  ]
                }
              }
            ],
            "usage": {
              "prompt_tokens": 2398,
              "completion_tokens": 161,
              "total_tokens": 2559,
              "completion_tokens_details": {
                "reasoning_tokens": 116
              }
            }
          }
        },
        "score": 0.6666666666666666,
        "ground_truth": {
          "diagnosis": "Neurofibromatosis type 1",
          "assay": "whole exome sequencing",
          "tumorType": "Malignant Peripheral Nerve Sheath Tumor"
        },
        "token_usage": {
          "input_tokens": 2398,
          "output_tokens": 161,
          "total_tokens": 2559
        },
        "tool_calls": [],
        "tool_execution_history": []
      },
      {
        "sample_index": 2,
        "input": {
          "diagnosis": "Neurofibromatoses",
          "assay": "assay by high throughput sequencer",
          "tumorType": "Nerve Sheath Neoplasm"
        },
        "response": {
          "success": true,
          "content": "{\n  \"diagnosis\": \"Neurofibromatosis type 1\",\n  \"assay\": \"whole genome sequencing\",\n  \"tumorType\": \"Neurofibroma\"\n}",
          "model_id": "openai/gpt-5.1",
          "usage": {
            "inputTokens": 2411,
            "outputTokens": 913,
            "totalTokens": 3324
          },
          "attempt": 1,
          "raw_response": {
            "id": "gen-1763583716-SvYjzb2pR7JjpFFueMY3",
            "provider": "OpenAI",
            "model": "openai/gpt-5.1",
            "object": "chat.completion",
            "created": 1763583716,
            "choices": [
              {
                "logprobs": null,
                "finish_reason": "stop",
                "native_finish_reason": "completed",
                "index": 0,
                "message": {
                  "role": "assistant",
                  "content": "{\n  \"diagnosis\": \"Neurofibromatosis type 1\",\n  \"assay\": \"whole genome sequencing\",\n  \"tumorType\": \"Neurofibroma\"\n}",
                  "refusal": null,
                  "reasoning": "**Narrowing down terms**\n\nI need to refine some broad synonyms to fit schema enums. For \"Neurofibromatoses,\" I\u2019m trying to decide between \"Neurofibromatosis type 1\" and \"schwannomatosis.\" Without additional information, I could choose the most common term. Neurofibromatoses includes NF1 and NF2-related schwannomatosis, but NF2 has a new name now. So, I'll go with \"Neurofibromatosis type 1.\"  \n\nNext, regarding \"assay by high throughput sequencer,\" I'm considering various sequencing methods but need to be more specific. Without context, I might treat it generically. I\u2019m thinking \"targeted sequencing\" could be a safe option.**Clarifying sequencing terms**\n\nI'm examining the term \"assay by high throughput sequencer\" and how it fits into ontologies. It usually covers all next-generation sequencing (NGS) methods. The schema includes \"next generation targeted sequencing,\" which seems relevant, but it feels broader when they asked for something more specific. While this term narrows it down, I'm considering whether \"whole genome sequencing\" is a better fit. However, that might be too specific. Since I lack context, I'll interpret \"assay by high throughput sequencer\" as a general sequencing assay, aligning it with the term \"HIGH THROUGHPUT SEQUENCING.\"**Choosing specific terms**\n\nIn considering the best term for our enum, options like \"whole genome sequencing,\" \"whole transcriptome sequencing,\" or \"targeted sequencing\" come to mind. However, \u201cwhole genome sequencing\u201d feels right for DNA-based high throughput, while \u201cRNA-seq\u201d would be used for RNA. So, I\u2019ll default to \"whole genome sequencing.\"\n\nNext, I need to map \"Nerve Sheath Neoplasm\" to specific types like Schwannoma or Neurofibroma, but without finer details, it\u2019s tricky. Given the instructions to narrow down broad synonyms without making up information, I might lean toward \"Schwannoma\" as it\u2019s commonly recognized.**Refining diagnosis and tumor types**\n\nI'm thinking about the term \"nerve sheath neoplasm,\" which is a bit broad and neutral. \"Tumor\" feels too generic for my needs. I want something narrower but still accurate. Since the diagnosis points to NF1, it's likely to be a \"Neurofibroma,\" which aligns well. \n\nSo, to summarize:  \nDiagnosis will be \"Neurofibromatoses\" mapped to \"Neurofibromatosis type 1,\" and tumor type will be \"Nerve Sheath Neoplasm\" mapped to \"Neurofibroma.\" For the assay, I'm sticking with \"whole genome sequencing.\" I'll return the same JSON keys.",
                  "reasoning_details": [
                    {
                      "format": "openai-responses-v1",
                      "index": 0,
                      "type": "reasoning.summary",
                      "summary": "**Narrowing down terms**\n\nI need to refine some broad synonyms to fit schema enums. For \"Neurofibromatoses,\" I\u2019m trying to decide between \"Neurofibromatosis type 1\" and \"schwannomatosis.\" Without additional information, I could choose the most common term. Neurofibromatoses includes NF1 and NF2-related schwannomatosis, but NF2 has a new name now. So, I'll go with \"Neurofibromatosis type 1.\"  \n\nNext, regarding \"assay by high throughput sequencer,\" I'm considering various sequencing methods but need to be more specific. Without context, I might treat it generically. I\u2019m thinking \"targeted sequencing\" could be a safe option.**Clarifying sequencing terms**\n\nI'm examining the term \"assay by high throughput sequencer\" and how it fits into ontologies. It usually covers all next-generation sequencing (NGS) methods. The schema includes \"next generation targeted sequencing,\" which seems relevant, but it feels broader when they asked for something more specific. While this term narrows it down, I'm considering whether \"whole genome sequencing\" is a better fit. However, that might be too specific. Since I lack context, I'll interpret \"assay by high throughput sequencer\" as a general sequencing assay, aligning it with the term \"HIGH THROUGHPUT SEQUENCING.\"**Choosing specific terms**\n\nIn considering the best term for our enum, options like \"whole genome sequencing,\" \"whole transcriptome sequencing,\" or \"targeted sequencing\" come to mind. However, \u201cwhole genome sequencing\u201d feels right for DNA-based high throughput, while \u201cRNA-seq\u201d would be used for RNA. So, I\u2019ll default to \"whole genome sequencing.\"\n\nNext, I need to map \"Nerve Sheath Neoplasm\" to specific types like Schwannoma or Neurofibroma, but without finer details, it\u2019s tricky. Given the instructions to narrow down broad synonyms without making up information, I might lean toward \"Schwannoma\" as it\u2019s commonly recognized.**Refining diagnosis and tumor types**\n\nI'm thinking about the term \"nerve sheath neoplasm,\" which is a bit broad and neutral. \"Tumor\" feels too generic for my needs. I want something narrower but still accurate. Since the diagnosis points to NF1, it's likely to be a \"Neurofibroma,\" which aligns well. \n\nSo, to summarize:  \nDiagnosis will be \"Neurofibromatoses\" mapped to \"Neurofibromatosis type 1,\" and tumor type will be \"Nerve Sheath Neoplasm\" mapped to \"Neurofibroma.\" For the assay, I'm sticking with \"whole genome sequencing.\" I'll return the same JSON keys."
                    },
                    {
                      "id": "rs_01428577ef8df9cf01691e26e7372c81968ac87d97b663f712",
                      "format": "openai-responses-v1",
                      "index": 0,
                      "type": "reasoning.encrypted",
                      "data": "gAAAAABpHib60ubFLVQQsvPvST8KOTldS31WeMAGIgZYgYDbTIgDpOcDxndROoyi1OH8NpB7Z0wPBx9de5dYIZpJc3lOd3jKskDFLZEeNSAxqj0e1mmDTAvhl7Qpn8jbHnfEeLKQFFicJNgTSUD3lcclC1h9zGMYfnUVceGSsbs3F4zxDH71j8UUFKArWYkYEvtuzbLWylVYP-AeQG46Th2QxqY-mEE0wn2_RSxu-0_HeTkTlfEAPKrtgA4vTNgGQYD9msRpXu7fJAdUBHiYrVTqKZVHnb31OtWuzfWBLS31K_85wrqxjkkxMkd2esrReYTfcQiqVG6SSlbcAI1O7rrDsDno--MpPhmVNtudrnXjqLm87LaG_Bljfh8G7JMU6vG4KoZ4ztQrXRp9iWaJrk17LfZuhMjtmdm_aGO-tkAfwWpDTS3HO-Qb3mYHODUIv8IV5BCUWdb9QzQJ-AIy-iGjtdQMk9AKXZhnxpBwKixIPw4-xzaet3erpuIFNXRrQQh_oFX5WJx4b12f3Cr61wqiqZEoQt7hfbZvaHu_F_K29LhlVa04q13ZHCHHvH_bSE23c6WOBsH4OEdCbOkNVtn4V9pCqiCX3Wr2wopprq3faeWkt4a11ZVVoIwJPV3hY0qvPCreqz799KV_574nKpMUnRT9lRXCub8Czv_0BxWnBWG3RlgO5WIyz_huwUsgVy-uwa6ceV_wlRjSFknM00IIWRvzqJBjN5gSXbMVuovPEXQ9DQdm5zYe8cE815GmVhUOWoTO0EomIoh1L34MuI7nreo6JTm50WJ8vbwSpyajJuV0vAsqPOx52LJ_42A_4yBJ3kJYhO6E8p2WoQUJHr85jgiGVQxqmXxl7Lg6MMi5Vv6uLOkHBdxl0jXY8KeV_vWP1bcznnYfRh-qDwOYAwRkVjbLVRURrUF21IYtHwuqxU8M21ApjpUoMsO6D3a5KePD_lyWnTcG4nCvp1Cjz9oQWFbql2Wj24ebQHQD3QF5UHccLAnx7v-YwVDrG7wD34nSaHS6wxIRIU54Aj9xU6wzfBTbznftnm1QJxcTqYcIxBjghiXrMY6Swxsx1jsE3LdGNccsISvqr4ouI_JbHneep_3blsqEK_UVYiWI6dM0U8RcdJxB6PLQs8BDB6FBiAcrb4js4bWMZHE1JE1PQytEt-UMKMc1ri4ADD8-aWYkau02m1Hp7BuHZ1WOEoU_mQlQWfToT8e8P4wk7uHAMi9Rh4j9FP8WzT_Y7nHdrAb1S6VXQB9kDmtXXwb7Tn_wOBAFqIHu0_C0YFCEqJCQdDoFCefQ84CemVjJVDdvYdKE4LYjsxeVTJaOvxyWS1QhQf5hBYOxCTafXWoBO42rA6J0B1PhXiP2j1E4eLVPfRKRypQyKm_tdXk09Pl4qZp6PVoXNjZ7YPilu3l6sUHbTasSur4cwq1vqUA0AHNiox5JEZw0lVbL_HCpOhWipYBaHG23zQgiovLZxQV8qwIZN0pipsnz2rNQkwHSqgIM5J1hxcXLN2zpp2laMAD_Mc1Ewd3ahV9xLUuOdGPLBeeGmYzMn85yruiVWrBqHNSWxy7LqvTTJjQMxfBYq9hMAtIDRkw2k8OI-NibQOPjGP9lMwQQnHel4OVfxQJOxw7xjUJv9q6WtajrKXchU9f1qTY810FDHv9RaES2C4UtYyZiLAHvZNznchsGqrZqeR5pgXJp_-1DGx04sL0H3vBKh-iSV0-pCSFQO6gQG1mzLhDskEJb-1e3qNzWfb7y84Pwo7UlPtxAviazS70-ZD_NgfbyIthstlpQBsRsFpfVuykxPw-Nq_0K8iE9jbp6bPfCuc7lkap28dq5viwihhx0NvA1OSlKDxltUnH-qedjbLlfb3bz3ceWj6KbseWx4chrc1FeknoYZbvspwUfA0a1b-fEudYRnr6R5TigMRHIQUQUs2BzLW-epZShkGtOD9hubiJOU4oWjlaEZ1Aq_6M5TB8IWoQXf2a5icvMO26QiEGP64i7zqWbaPmCQ6fztAZfd7qB7Sjxw9sw7RslJW3R5ZX-NbvPynGM5x4AnEBr8Z3HgG3k8IchQP_mw2h2_X0BWCIUYODTzhKr3xuEMQJ-sDU1olpG4KqWfQ17ZVgBcLcFINLMq_W9GYLd-Q8P3u3uz1NXkivwSUNwVp1k2XafeRnVoFRbNVprZ4cP2LEzsxUEjnPym7NPQzy-CpQFYmLv9r5HCIjoCRYSXeMiLvJvKm6HSZHaYNeqsSgGURxdmEWMdBI7_FPRdKwDpsy3K7qFspqvtPJxLZodv_0iNoVpFGs3va8J1hYfKe3Lg7BJlv4Mn2Nvov2W39R5jEKcm_tLM0qcfqSP9F0WnoyGAd89HMh6bIynXQgnh0frwieZauxV1C-wLv_qcb_mrG7a0kMhHVIgJBrS-PiNjRi1Ej64d2YrbtS-zj8Nr9TUGhhMFxamuPMAJCnK4-HF9U1TaOcv81Q6Oo1d9u1v617opFF2TN1wSJktwRuTDR4EQc-E6SNiUEZK5jZUz16saC4Q3Cw3vuKibSiUfyNvUEG_9_bgAeMSaRyWdTTkK3mB8ewLqHI2CdYh2J9Aptt6OvPaWbyooOwFHGh4Xs21GidYhqMo1oET9MpiBOoPztWR-Kt4FoTcNVNQ2zVDLSPeK1hhSTu-aLehGKFtEWy_1wGzblLpAe3vDTdmX3CbOOANHBZlm18eFVfTKp7r2xhHApCf6jWnw-19S5LSJiR2akCn7zXR0sfK10yLF7Gtg5mJx7rOjr4JPW8gPCLohPWkq4C1AS9E5fUNz1849CPrXJJpqyFiFOV1RRzcNUxLRYvIQVpWL565pIS4psX-HpR7l7o1STDMkvwvULzcZmqsyDo1BEFdf5DS1UkcCcrFe96P0Ijzi3L-ULWoxxIsQs0iEGGEBRjQgc5hcJR9PfUB16C-mSoQfEB2_a9sgg31XXPJofgeuVoyZ1ph_NxlrWG_e0VmFWPw0Xn-A9_mGF9-ax9JjFCZFFoXNPumKtIyslWNXdfEtuHQGgwPzmKJGCKs1gmfOlcuA27aOCRa5YksdO4sbEC-wq4wZj7CCHD32N3qs6cgoWcjYq_kk0BuohDZHl9Sr97ZeoRSSSSnhheI5h69qf33c0V4eaLvkSiM6Tjkx0xTVdu1oTcxdMIMqUvFn_bd6Z_gRDuv-52lILwnM5lpJcswFmUp_56GUmxcAx0tTQ06iZcPkuEwQfpl_VwiCxHQkBgCFx7SE7Xsz_3QJ4OCGH6qRuJD17oDNwGd8dKL_djeBhYGHztpkZWV-hk8d1eX3U5i5zNbZbjL6Z6YvzKw4PqnREf11XHPbWYIVekmRgh5wFCQV2e5OUs5W9Z68AZhUuJLQ9rzJYysTdLUJU7bzflKuSItj0v1LFq26aX5bEIYx60pBBOoKXxZaFm8Rc9C3Nz8vpOsMUCeHulRRuykry8HLugGz0DhnqENdPjhOLtLDivOqrfZYvwGJESIsNcoCUNgt60jvmWIEK6XyuScewqhP_PdWyD3Gt6ORJfjp3dj4mjdLmUqbT-9hw3R32a_WxnCR3Xws_9vCPJwCHFNMSimuydhmrQmLhpzX3X98TerDlUB5y0yf-9yuOD6gFEJ0_OxRn2DMr2evMxPQ2TnwKaiuZssFW1zMvUwcVv0GLs8zvy1LadQOfbOV3TAuD-3H7SvvHBnG-eBM13u45f2y7mD12ptFuE6rEEWOERJqdVjNZaLB3SRjP91Q41zekwelXtMV3B8DZKkDL3UdHTUBXYpdjaE-tUcDoZd-f7tOcU15sVkqv7CLbTrD6x54dR7866H50b3UKSEFDsNyu6u4vsWljNShO2huWBvl9BShfd7azY4t5Fg8PEzxBXOlaWjHOi9Lh2IfJavW6eaNLFftWYafO2AjalBprwYNJtt_0mlcJQK-POpjhs_7DBg4-2AvppFn9r7Se_-LsdFBq8BePs9FVSka3cPgB4hCILPqO8aKgmd8FUtt1_-DVwEY4F4lmgy_GjAD6jeNI5o4P-fmOiyqMTKzs9sx1JcCHAi4WMLjuxS5ZFTBKSXGaPPbN5EON5HLrI0nqcdpqeRYGfu15ETV5B5XPJKZIjvrY6An9Gj8yefmVYMZ7twvI_OKvJnz-7ztPMPQp61erAfmzN5tZD-eKVN2pnTgWH9s5-QM0RfNNL3MGfQcvanDNwKrABgC_dza6GNLC0h1DtvqTlyfsZL4kN8hOzsqwm5O-I7cbwfS-3Z5SRCFx5vO3hz6fRMr37tSSsY5gi6R5LOQqoZEuW50VnvludzhhNr5hJA6-9DODlfY1rQhwWL9NYg-PWw5TbzOxADHc_Lv1b-GYWdL9dEOmE5WXt30jsPaO-ggBuM6BVWzc3YLqUfbOtvHjWvmg_K8kcNxEwqlsEuJsQ7zqeoluXnWvhI2wsgyPQFB2IJz96RB-mNqPQdr_UbePy0KqPZxsWHfjOhtIcQzpjuizRMpco1M_pBkI1wLanJ2tEYisOJeBEIe0x6Xqks7_QKlQNZzEMU_D0rgarZC4SubsHeeNrHoWhm8CMfju9R-LD3BMYZR0IGjL-o7EnGtERwvu-fmYaA8fZ73ujRy-UCIq6Q92-uFCjKfxHjhX4mFhkPnSMbNAnWAdmAompyABu-36sO1VpdFVGmP5BKIJoLGCYXLDNpuaaj7ouItKuoHUVfhjNfsqGs16d190nrNQh_KWP0M9gOfeu5ZqM-zmQP3S21OfIOeZEOiVdyNDU4XomAz6_LW_N7yU4SsYh0qQSn1oHgBQIh73VHwjdDeoA6PtyCJPdIYD22-NAFmlfRxB1bIJwPlCAteooTRHEHHUPggZyHCUwZNT8YZOsrDrVRSaiqj096hDAinspPIciu5iPwTpVpnw4f1VyUAoJzemhYH9AVSXfoGIg3fj2QS4N_amuOuy6ju1fUw5DvFoNdiBi5o4cG_QHTf8RyErxFqTIYpJ1XoXooQUe9Xyf9EbDJl9JtoEVzM1JCYi8v5cBRmFOG_7heG6LBDB-9RlHLpkgP_tqv7ZYh3tQ_mvjBJ7ebYcyKG8i8XuFKDT6WW01LYCqz7uRMU6aqPWMkisIY5hOCoU_H_vAHUlt_DHfRg8G2Yeg26wENrwG11pUeXrPbb7EkVWf7xu7e2D74oPn8d1d46A1QFWXuMMtomGktY1RA0W-3IWmothBaiFBubUD7mijiNfb_bZduZyH7-vH_z2PyopVAq5wJMPGqX2SRLpvwUQmjNBwnzsHbMGlfwJn_NNZUOucMXPGnUSyjkNu9dtz17oejWfNEoZE0lljOlL-tN4TQ7k3_gj8HDBZ87RcgC5ZXwp675alqCyg1Ab8NK_40bm_FI1NCA0mP_I3_8msgWVpWpm7reLT_V_p_n34VXw37oIeHymOkZJR7abb34jOGERNAHqQH0j594Vmb-pEtYbbcAA1XuC2RsHCZSBtElHw8tKC6V_4A4W9fIRviAISGnmDTCX491SmciNzui0xOQ3VL6zCX1Qx_ehCBJl017_tNHBazsQTXH5k2G6XIxCWK8vcdiOpIkFJkqbgWHAQQN3ZJ1potPGHS7ipl-x1HkZaCWzUi_IX0bVbRsddWeYWFZUfe__RYOQPBX93gy43IZdv2Q_xTDF-bMWSiqI2HR2qVV5Rt9cDFUMPyhXE6O6ZLdIOrYwjPN_IUR2NVcUsybxIFG4m4JIan83luQKAT7KX_5AF7xBBDsU-6A6IM9dBQq7OMqchIRGu8sHZhMNaVwzEnbOuZRtxi_JhQhWdGh8iKXIOwBZqTtVi1nVly8NBSCCRbZo5YxeW8oK1bUMmBdHAlJgJ1bBFHBhUuXW9jlgsPgewCrG8ihYUpoNlSXw=="
                    }
                  ]
                }
              }
            ],
            "usage": {
              "prompt_tokens": 2411,
              "completion_tokens": 913,
              "total_tokens": 3324,
              "completion_tokens_details": {
                "reasoning_tokens": 867
              }
            }
          }
        },
        "score": 0.6666666666666666,
        "ground_truth": {
          "diagnosis": "Neurofibromatosis type 1",
          "assay": "whole genome sequencing",
          "tumorType": "Malignant Peripheral Nerve Sheath Tumor"
        },
        "token_usage": {
          "input_tokens": 2411,
          "output_tokens": 913,
          "total_tokens": 3324
        },
        "tool_calls": [],
        "tool_execution_history": []
      },
      {
        "sample_index": 3,
        "input": {
          "diagnosis": "neurocutaneous syndrome",
          "assay": "spectroscopy",
          "tumorType": "unknown"
        },
        "response": {
          "success": true,
          "content": "{\n  \"diagnosis\": \"Unknown\",\n  \"assay\": \"magnetic resonance spectroscopy\",\n  \"tumorType\": \"Unknown\"\n}",
          "model_id": "openai/gpt-5.1",
          "usage": {
            "inputTokens": 2399,
            "outputTokens": 323,
            "totalTokens": 2722
          },
          "attempt": 1,
          "raw_response": {
            "id": "gen-1763583738-LEEioRbZQudTl8LeGv5N",
            "provider": "OpenAI",
            "model": "openai/gpt-5.1",
            "object": "chat.completion",
            "created": 1763583738,
            "choices": [
              {
                "logprobs": null,
                "finish_reason": "stop",
                "native_finish_reason": "completed",
                "index": 0,
                "message": {
                  "role": "assistant",
                  "content": "{\n  \"diagnosis\": \"Unknown\",\n  \"assay\": \"magnetic resonance spectroscopy\",\n  \"tumorType\": \"Unknown\"\n}",
                  "refusal": null,
                  "reasoning": "**Selecting spectroscopy terms**\n\nI'm deciding to go with \"magnetic resonance spectroscopy\" since it's a more specific term under \"spectroscopy\" when we're looking at biomedical imaging. I need to ensure that for cases where the tumor type is \"unknown,\" I map it correctly to the enum case \"Unknown\" with a capital U. After that, I\u2019ll return the output in JSON format. This step feels really important for clarity and accuracy!",
                  "reasoning_details": [
                    {
                      "format": "openai-responses-v1",
                      "index": 0,
                      "type": "reasoning.summary",
                      "summary": "**Selecting spectroscopy terms**\n\nI'm deciding to go with \"magnetic resonance spectroscopy\" since it's a more specific term under \"spectroscopy\" when we're looking at biomedical imaging. I need to ensure that for cases where the tumor type is \"unknown,\" I map it correctly to the enum case \"Unknown\" with a capital U. After that, I\u2019ll return the output in JSON format. This step feels really important for clarity and accuracy!"
                    },
                    {
                      "id": "rs_07e40e620fee6ac101691e26fb2bcc8193b5a03197d9f2c325",
                      "format": "openai-responses-v1",
                      "index": 0,
                      "type": "reasoning.encrypted",
                      "data": "gAAAAABpHicBN6qrWsaUDLfI6C3MppOOD6u0mn4UBVGV-DjfmzCMYduI7YJy8i8-MWm0FaWRZt06x8b-owoYxBNOSzWmcGiWTU7veCHJBy3-t416K2bCcvI8DPQwtrZdrC2A3tmNx9waxP2wOf7DVxfzWIpbNt4mWfrAHytZZitR2EqwnKCeT00PNrl2oDu7nS06G2CYO0PLn4liv_-FS1l-02zmavFaTkWXQSYQa2vXp_RLyrNhx4Db4C0p_y7TSyiLpGkcMnTTQGxh0HNrRPrnqIzTBKAsl0NHxMsL6RE2f5SLgUizZCnUXWI5cAY0Fy-OlNyKw2R1Rj-UQHbADbmbtEsTyLy_sWEUhSBKIwrdh3BTytgO11su9bdYWnIR9fU7V5QVqC7u3QljbWipfcIKw00Sq-mvmosbXKPQcpWWya_D5THLoVOuwBN4bzZYAk0dl9Vq0HGEX-TcfUuEAWh92yTW4pEAP8bhUNuoKNZpGG8MFixJrqvtnAzLFwmYc5byjHjeQ5IyuMu4CT8OXuIqWQbKO9L5peT1K86cfwl3EQYqw2yEkwUtg2f7Sixy1ckLX7kLVGDTvk0n4sOyFEClq42u-f-3cbeX3LVkCZ_YGAKNszj__lk8qyZNkNa83Hd7AatShEk8x2fZGv2_fHAVMvfU8f0IzTlFT70rNyRDhYmvSXNnuc1CYk3_AdgT1i-0gln0tSCeliQiOYL0s3NHFUqY4k6yT7KgEFBs_8ygfhvjZrMKHIoJoD_fEMsYp3BBfSV_IHMG6gQLg3kelMZLFAEqrwfB7YR_79mxjzozTHnmTqfZGqwY6CmGZa6e2cRgPbeZY8rq4ZlzBGv8_5wAcxVvMr-POkdnpoOMAeYiNIB_pUu1-zmexZVmYFcXHLPdjWFw4ryyDTt2IhzhLJJ_8qXjb9n5yD7ZxzuvqYnAKlzB3QAIIjbWPXBYLQV77AYT1mb0xfWAXRusuxCO3Q1WxVgnKqyd561921rrYom8HhLMi0yPY2IFaV775nfVeHKaO4r1uzGvIw_NDgGTw0ZLLYgUzwfgczBvTDHI7PpxkibGLbPOrRm-UkiR2lLDzvnkjjjSh5xj7103VHhy34moguPOwOa0HyioVteoRFq9WXwokPmIpJvlPSg0e94m98SLdbM5IO-oqtrIdOqRrbLP1K6X5BfMGvlWNPOzRO23X5_0bzixC4_VvYr3uqRjNjsylNLVYXHengFflYVsvQd74mhz2gB6vma2CLo6Kor3jrl08KTBGAorhUli-911pR-MLsZ59uAQU43Gl4CR7eOYc_FJpbOIrLOCGOvCLrHTgB85eoppIeNb77N8kRYQP8xDNiO7nUKT49f04RJEg2iqQbJ8W5O_G76pftqNW_laI0MeFn-ap3H2zs2nTGkjFSw8WhgbSdZpaFOAKQf_OMw_jtzsA78OdqroI6muOujWMor7HDQPJUlEom8JYNpDQIsU8vF50IwAXXRMNuvp0KQKuPy6dycl8XNZGm0SOlvjcBIRza4UwULweNX9zFMjdvwTrVibfjFID4bnHPMYObqSlzQjPsNQJ_AGCmTToUPWpXUW7knNAKZfQflYOEm5DOrZfbBcR5aVFyFn_5OaImiqC5cvkSRglih-FpBdGsh__QmmuDm18KroEOurrI3kP2Ad16wQPgIdb18oIZwFFMov7umVG9nJ9coyJsJeEimNqk0Ch4S2mcGHGE_PqZAj2LMrm2Af_YtnLWxi4Wekin2Ni4nafrE_v4LjPdQIzGwCGPRwOd9iwdCR6iwF2eBm5032lACPEI-S9j3aeplvysarTHd3Y9GfLabvQ_XoSv5N06XDOPssC0_cNBFMybdPzdJlbAPLEGvRv3Sg89fyJ6zqPnrnUgrxxbFfx_HZhivRsfeZ7lJmqTvDLQ_Iwq8K0ngPGShEhRZr4FFBHllINa7mlr5m8WuA66caQr3BkMCXNUUZ9m3n2UIbynpibgjdeNbpVQQsYlYH_dt0K67f2IPxwhHB9ONzIM94RkUNGR3kaWGDu8WHrOI_0f3phf7M_mTCuyurCXL7B8QRkG1MKq3XL7MF2kZ7o5DuXBA3kBtzd8DcJYhSQTj6957jP5R3QZKFXtWoR89UYDebE6XI4Hez5wmjk3RuaScSpdC7P1_6pxDQfUl37Lw2Hb21z5OiyixmbFhSr7xa_AOklaNXUtci24pocs48_9Sje1zZmPfD5vBEQJgsmuqca7dFPa0-Yuy5UOe0Y7xEawSMt4-EIgUdD8FA4ECWXZcpCURuE2Iuh4krr9dMM4HeJPdSwh52a_kbz2YCRu38rYuwV7s9qFUPl2p2mxfnco5X4lKVRcdHgpUhA3uU7gr15FnIhANysj9ljE_EkfGrqej3o7q_PZJL2TNiMRec_P3eo-uce-od1Nq2Va4i3VQT7zwt6Ay5gELjqNQwWgqOK6iSmJSjYY3iU_drOb6vogN662T-fYUvSBTE6rf1Cd1hA7tc20HV5vQ51IfcHLbTDWPfQ9H4ZHCjqXA855hra3A8ej2Na-3GjjIENXdN-XhcBGlxhEoeAVGaelZPEIvTC_GUa2JmKKI-ssrIBNMGnO-8sCp39VwrDnlEv1j32Qg="
                    }
                  ]
                }
              }
            ],
            "usage": {
              "prompt_tokens": 2399,
              "completion_tokens": 323,
              "total_tokens": 2722,
              "completion_tokens_details": {
                "reasoning_tokens": 287
              }
            }
          }
        },
        "score": 0.3333333333333333,
        "ground_truth": {
          "diagnosis": "Neurofibromatosis type 1",
          "assay": "conventional MRI",
          "tumorType": "Unknown"
        },
        "token_usage": {
          "input_tokens": 2399,
          "output_tokens": 323,
          "total_tokens": 2722
        },
        "tool_calls": [],
        "tool_execution_history": []
      },
      {
        "sample_index": 4,
        "input": {
          "diagnosis": "Not Applicable",
          "assay": "immunoassay",
          "tumorType": "neurofibroma"
        },
        "response": {
          "success": true,
          "content": "{\n  \"diagnosis\": \"Not Applicable\",\n  \"assay\": \"immunoassay\",\n  \"tumorType\": \"Neurofibroma\"\n}",
          "model_id": "openai/gpt-5.1",
          "usage": {
            "inputTokens": 2403,
            "outputTokens": 142,
            "totalTokens": 2545
          },
          "attempt": 1,
          "raw_response": {
            "id": "gen-1763583745-jCNFHA4iQhWKzHIEhIbl",
            "provider": "OpenAI",
            "model": "openai/gpt-5.1",
            "object": "chat.completion",
            "created": 1763583745,
            "choices": [
              {
                "logprobs": null,
                "finish_reason": "stop",
                "native_finish_reason": "completed",
                "index": 0,
                "message": {
                  "role": "assistant",
                  "content": "{\n  \"diagnosis\": \"Not Applicable\",\n  \"assay\": \"immunoassay\",\n  \"tumorType\": \"Neurofibroma\"\n}",
                  "refusal": null,
                  "reasoning": "**Adjusting synonyms in JSON**\n\nI'm thinking about adjusting some broad synonyms using enums. The diagnosis \"Not Applicable\" is already exact, and \"immunoassay\" is also exact for the assay. For the tumorType, \"neurofibroma\" needs to be lowercased to match the enum, which has it capitalized as \"Neurofibroma.\" I wonder if there are more specifics, like comparing \"Neurofibroma\" to others such as Plexiform, but without more context, I'll just capitalize \"Neurofibroma\" and keep the same JSON structure.",
                  "reasoning_details": [
                    {
                      "format": "openai-responses-v1",
                      "index": 0,
                      "type": "reasoning.summary",
                      "summary": "**Adjusting synonyms in JSON**\n\nI'm thinking about adjusting some broad synonyms using enums. The diagnosis \"Not Applicable\" is already exact, and \"immunoassay\" is also exact for the assay. For the tumorType, \"neurofibroma\" needs to be lowercased to match the enum, which has it capitalized as \"Neurofibroma.\" I wonder if there are more specifics, like comparing \"Neurofibroma\" to others such as Plexiform, but without more context, I'll just capitalize \"Neurofibroma\" and keep the same JSON structure."
                    },
                    {
                      "id": "rs_0c409737a828b0c501691e270284508194b98ad3b626608877",
                      "format": "openai-responses-v1",
                      "index": 0,
                      "type": "reasoning.encrypted",
                      "data": "gAAAAABpHicHf6HwPyZTFmFfLjy7u0GoVocsf-iIUK-daX6CzJFUo3UV0jKDVdtMQcmIO4WbjG5RxS8oXjagWlQ-o7HvLcaBCcHeEqX_VsMyVslX32PZHZ7Q1WTPqbgJeWhyl2p9Iu6ie2YePljllCH6kr-CV3Qxxm_mow9Etfq45ErLT_nOmkayFjA4ojpTOiy62IC-ImIkKCPMW5KWumfAk_uwizHM_ywKJFn4XaXjr3JyqsxBEGxBUI84nlToI7YYcs-1_z9FE6W3sDzB1N5gBeqIvO4JhHBVwJ40kbXSH7HHp38e3BhX1kTWcj0e5Zjlv4n9IUeNKmn6jZuqrz3djDPUrkP0zVzQ6QW9xxgy94dcuhMoQgnFTiiHC7tKUjFFwprpON1ZUMLlPcezPkR1Pkf7I-OtbPinUIurGht9YSsgX8VQMOFo4TmeakqskOy_OY2CW4j_Dc876Y87XoH56YOr5ZGGAIkYE9iUd3BI9vzk3dP37rgkG1qgKuC3S8nyCfxWsfRLp_335KrDJrdD2zcgW5wdmcLeH_Uivh5ZZ7qVTAI3cLttMpO-ZiQcYtfrUzQ61_g2wLjFU9JjrMV_rL_AdcZXPOng9Oe8EvATKeEHY2W3oA7xzKEngzqxJcXWdwPy7PxmIw2_NDOVvTPiERJ0qci8Es_58c8MCm95C9aoftmZi87UXFL7HiolQ6TPScJNbKP0tTmmi2XQKlNMrbd0_0iYciL63hYbYFarr51TNngpahL6zMa9AMp0OJCBlbzHiszBy6pgWdb3ZLKnwE3_VDi3mBc9YKK9r-wffFr3Jg0iPY42lYYsTbKIObAM6O1PsTx0iKi9VowHndwilCCf-LDGhQ-t0J2b7rpGGWsw9RBdBiFweliih8q3LzLqQJw2cqvBTT_3fa2jcbyXSroESxscaTQLYuyvg4ZoDFin-4SPcAU4-zGLgldDzUjbmHAmCsd2nV2Bktaa6ZAGfzJvFX9BS_Ks8mT59sWKoq_DxglNbkkthX-TuqjmpDqmo8Q80vXlynsusWHmIt-8NHYSLwn1Fj3wxA4MSICKBErYCdbLgaceI-vHTTSpTEzWNm48a01FxwHSvZEgigI_1RvQ_SoxaOLuOWtH503mqoVMnKY4WSQjgije9vIykOauG4oukt2Dvkh4DosjqZ1hj1cOSk75l3tZPJ-4EoKWy2xoIA4H_7GWb6MYSUdWBA_FN8gSxD9sdG7qFtEtJxb7xap3kNCN5o9QncQW3a_xEfZnx00Q4hHOPQW-p1Hpn7XZTZSoAyZ6Fm3NTe3pPchvM1vqxS_G1roUTgnn1_TDvNLVv0wTa0EXhk2lIQEClfEBnjHPjcFGubj9qf7J-3_isoFkNOOEBhswA7cIWJg7q-9yCF2vB1pm6Vy8RkkaQiF92Ul4RsHm"
                    }
                  ]
                }
              }
            ],
            "usage": {
              "prompt_tokens": 2403,
              "completion_tokens": 142,
              "total_tokens": 2545,
              "completion_tokens_details": {
                "reasoning_tokens": 101
              }
            }
          }
        },
        "score": 0.3333333333333333,
        "ground_truth": {
          "diagnosis": "Not Applicable",
          "assay": "immunohistochemistry",
          "tumorType": "Cutaneous Neurofibroma"
        },
        "token_usage": {
          "input_tokens": 2403,
          "output_tokens": 142,
          "total_tokens": 2545
        },
        "tool_calls": [],
        "tool_execution_history": []
      },
      {
        "sample_index": 5,
        "input": {
          "diagnosis": "neurofibromatosis",
          "assay": "plate based reporter assay",
          "tumorType": "benign neurofibroma"
        },
        "response": {
          "success": true,
          "content": "{\n  \"diagnosis\": \"Neurofibromatosis type 1\",\n  \"assay\": \"massively parallel reporter assay\",\n  \"tumorType\": \"Neurofibroma\"\n}",
          "model_id": "openai/gpt-5.1",
          "usage": {
            "inputTokens": 2407,
            "outputTokens": 302,
            "totalTokens": 2709
          },
          "attempt": 1,
          "raw_response": {
            "id": "gen-1763583751-HkWlpzQTMnjsFrzj5el0",
            "provider": "OpenAI",
            "model": "openai/gpt-5.1",
            "object": "chat.completion",
            "created": 1763583751,
            "choices": [
              {
                "logprobs": null,
                "finish_reason": "stop",
                "native_finish_reason": "completed",
                "index": 0,
                "message": {
                  "role": "assistant",
                  "content": "{\n  \"diagnosis\": \"Neurofibromatosis type 1\",\n  \"assay\": \"massively parallel reporter assay\",\n  \"tumorType\": \"Neurofibroma\"\n}",
                  "refusal": null,
                  "reasoning": "**Mapping diagnostic terms**\n\nI need to map various terms to the appropriate enum classifications. For the diagnosis, \"neurofibromatosis\" likely refers to Neurofibromatosis type 1 (NF1). So, I\u2019ll stick with that. Regarding the \"plate based reporter assay,\" it seems the best fit is \"massively parallel reporter assay,\" even though it\u2019s more specific. For TumorType, I\u2019ll use \"Neurofibroma,\" since we only know it's benign and aren\u2019t certain of the subtype. Then, I\u2019ll output the JSON with these values, keeping it concise.",
                  "reasoning_details": [
                    {
                      "format": "openai-responses-v1",
                      "index": 0,
                      "type": "reasoning.summary",
                      "summary": "**Mapping diagnostic terms**\n\nI need to map various terms to the appropriate enum classifications. For the diagnosis, \"neurofibromatosis\" likely refers to Neurofibromatosis type 1 (NF1). So, I\u2019ll stick with that. Regarding the \"plate based reporter assay,\" it seems the best fit is \"massively parallel reporter assay,\" even though it\u2019s more specific. For TumorType, I\u2019ll use \"Neurofibroma,\" since we only know it's benign and aren\u2019t certain of the subtype. Then, I\u2019ll output the JSON with these values, keeping it concise."
                    },
                    {
                      "id": "rs_0e308c527b331c3701691e270801fc8195bc4483c854c2c021",
                      "format": "openai-responses-v1",
                      "index": 0,
                      "type": "reasoning.encrypted",
                      "data": "gAAAAABpHicOLmkFaEYhAIrH3eogUYshGwg2-qOk0uQF5dvSMl4mjfGrNuwY_l2ApnRoDTgUl67vAquMIlkJx0mciCAgXv6cFEdB6bc0J7mXo4qlLwqeXZPCWnz__Z9HXSb0FyMTq2DRY8S0gB9Mo1KJulJf7mO90Y5UR1ym8wjGDJt2m8cGPlu4pb0rUre21-JvfIG1fUhh2zJcyuzBw4GK4i2fJ8S16ay1RVDKbx9UgrquEASzM6uz7Wu56g5_eqLEdkzSensuWkmwlRLKpSJH4pBwYIRvq5aeu0-nEjl59fiPwFBfsZdNFnF1M2-OS69E1XVIcgJFlkGEZrN6b6Bt7iuviIxauMhxDmgmAzBBzgtMUdez-5xFJmbBHLTwAtf93ToMntemryzZYU_7R7QCWD5G6VzKFIzPTopw6Mt5MzTZSh1IEGiAI0vXVuVOD8BrdAD2KFaEiNDc_7nv8cgO0NT5ODl8RaGl_NRUAB_vFNMK6XCDSNlnG6zO9EXasWuqI6KSwKWbsPq1RO4tjtySM4qbxsc2QPCefMVDawECEvunq9MUfvMRnoSHycxPkThp4EzCoG_Xqc3xTyGji_NMLxxH45i1Bw6FiSJIjgSvQFWAazVvkuATL9jeFznGSTBuVa9af2KOB8DhcLeZfTg06pXU4tKd9OOaYzPCMIFgKMxglN2mMWE0et6JK7beg_sqFJ_5ticBMkat1lDL-kFE3LUfCkH868Y9MkGmw3_Tq-6BCidxtsPuCc1FeomOr_nGYerOwDNKIJ0PSwrgdwjEtTdNFNdtqeP3c7_zqH8pDlxyA02nlzkO2Bu0c1AlXW79cFz1eFQ7dsMrt1wzmWRKgGm0sq7988QJkYkEQLcgiruMJqgWgF6bUPz4iSgawpNESJ0BkmKUchqbxaurTvw0eT2-mmWGP0QW-rzAJ26Ll6cP6cDl2ETrH46ltV8hluJzOTSuEfzfMx1vbut1AgerLZVFSGiRvzd8ri8x6rDJBLBpl_scBW5V0TiJ2UXrajZrVyMWGRPDNHbTpHE-qQOwpcDRpfWFw2R_bwBjUK8OldIZH_HGe7GBcXtuMcX3yqnVrENTRDBIJavyzLSfi4r59Wcut3SYYI-HtWo36_b7CeHSDOWT-DOQ9faB-aouT9JuqHS-KgWDOpuVd_0YTRTI0BbaQC65qm9Oap_wkXJt0qJe5ogeMTMsQ3jNLuSG1S98jW88RXkCOtGqSxb8s1n1zLvuxnbjmzhiZflug7cD6cjkNdgp-gTpKQ0ypVv3HSu2Pp56MMEjKaW9z9OB0QfG411tNXHzvVms1Sxl5KbLC_HcsdOalv8GKhRO0X0aqrdB_zY0MZ1p7WYUqQhsIY1dy6EN0M3PnyA1PP_3Hz0tkCvVnpbPVYRLPdSvZg1tP92uxhHLcDKhekypryvaI58fUEIe7SqjUFob3YIyRsO40Su_utVhtIC3yCVwRvMznaUryOxBji_jwqn897MEJdDEElUj8Ep51s3P5KB42pUyMxGQ1CQpmYijGlXnk14GZWbVGcxrBV53IWCDxGkJbZ7g9xN7tnparSRHfNGH_m6WRAEhFJe0LV4dgCxOV6Fq4Fj3mGAYs6LD5BFaLoxaaIy23VMkGTV0wWWHrTpo1q4_vE6PFQb8no4KsEHgfHyTWmg825Lr_8rbTG0stfN5TwrDaEktNfSheBIBTU6YrLXrTot8tcyQ-yPq9OyJiNFvJ01ihWDJPEDWSSPpXiotzp_HDLi80R6g1csfBXnN1GwUMeYMcubsPoXnm6dkyzScYL64fSpPH08jU8ITOfSa4gZl5kX8sVlR9FLuME0C4ajv34LFtve0zXc_-Fm9sHPvqDLf4mjQUc2wtWKy4gRWQg_eB1khO9qB4fP6-AiXkSt0N9leNumlseK2LpfvJSyKt-HPRitlPkrFr9QbCxZnv5Bu1SdTYq2M8L-pn2L31ydksL7nKsce_roFTzq1oI1yl2KiZOGusTVNUxigsDz-yc95xQMzwpMhloGPR4041xy2UuN5j5quNVqMNHmkQNj2MpZZGog-vXcj9uOXl5c4vBPhmay8oxM57iihKZDBC83JYBpWCDasU7yXGQ5ptMEBzw1xtXhLfM5Lg1WmWZ0Kr6iWowDSQ5CLFicMbBu5JbCOrL_wD388DoG8JxPITTmnNRdJmnPaexlwgHwM4yvtLV1xE7B_oLbJ3IY_QNWpbbaUHe7SE-RwWxty1-wAg8cWGDR2X6ucfWWIEc15Jlm04zacWnp_3CEVGYvnpN7Uqg8pbRdIYHBuZc-yWLmMiLUcaTt9LkZlzmyChxb82SPf3DRAA-0nXTfrjg=="
                    }
                  ]
                }
              }
            ],
            "usage": {
              "prompt_tokens": 2407,
              "completion_tokens": 302,
              "total_tokens": 2709,
              "completion_tokens_details": {
                "reasoning_tokens": 254
              }
            }
          }
        },
        "score": 0.3333333333333333,
        "ground_truth": {
          "diagnosis": "Neurofibromatosis type 1",
          "assay": "cell viability assay",
          "tumorType": "Cutaneous Neurofibroma"
        },
        "token_usage": {
          "input_tokens": 2407,
          "output_tokens": 302,
          "total_tokens": 2709
        },
        "tool_calls": [],
        "tool_execution_history": []
      },
      {
        "sample_index": 6,
        "input": {
          "diagnosis": "RASopathy",
          "assay": "immunoassay",
          "tumorType": "NFIB"
        },
        "response": {
          "success": true,
          "content": "{\n  \"diagnosis\": \"Neurofibromatosis type 1\",\n  \"assay\": \"immunoassay\",\n  \"tumorType\": \"Neurofibroma\"\n}",
          "model_id": "openai/gpt-5.1",
          "usage": {
            "inputTokens": 2401,
            "outputTokens": 1181,
            "totalTokens": 3582
          },
          "attempt": 1,
          "raw_response": {
            "id": "gen-1763583758-gZu74fpn5C0GVBp607YR",
            "provider": "OpenAI",
            "model": "openai/gpt-5.1",
            "object": "chat.completion",
            "created": 1763583758,
            "choices": [
              {
                "logprobs": null,
                "finish_reason": "stop",
                "native_finish_reason": "completed",
                "index": 0,
                "message": {
                  "role": "assistant",
                  "content": "{\n  \"diagnosis\": \"Neurofibromatosis type 1\",\n  \"assay\": \"immunoassay\",\n  \"tumorType\": \"Neurofibroma\"\n}",
                  "refusal": null,
                  "reasoning": "**Narrowing synonyms for diagnoses**\n\nI'm considering how to narrow down broad terms like \"RASopathy.\" This term encompasses diagnoses like Noonan Syndrome and Juvenile myelomonocytic leukemia, so I need to choose the most appropriate specific term. However, I lack context, which makes it tricky. I wonder if \"Unknown\" or \"Not Applicable\" might work, but those feel broader. I realize I should focus on providing a precise equivalent based on the options available, even if I have to guess a bit.**Mapping RASopathy and tumor types**\n\nI'm thinking about RASopathy, which includes conditions like NF1 and Juvenile myelomonocytic leukemia, but the latter is less commonly labeled as such. In a pediatric context, Noonan Syndrome is typically what people mean when they say RASopathy. Since we need to replace broad terms with more specific ones, I'd choose \"Noonan Syndrome\" as the best fit, even though I'm wary of mislabeling. \n\nRegarding tumor types, NFIB might refer to Neurofibroma, but there's uncertainty about its use as a gene name instead of a term in the tumorType schema.**Determining NFIB and RASopathy terms**\n\nI suspect NFIB is a code rather than a direct tumor type. I'm thinking it might correspond to \"Neurofibroma,\" but I'm unsure since \"NF\" already exists for that term. We have variations like \"Localized Neurofibroma\" or \"Diffuse Infiltrating Neurofibroma,\" which complicates things. Since NFIB isn\u2019t valid, I\u2019m leaning toward labeling it as \"Unknown\" or \"Not Applicable.\" \n\nUltimately, I\u2019m settling on returning the JSON structure with \"Noonan Syndrome\" for diagnosis, \"immunoassay\" for the assay, and \"Unknown\" for tumorType to keep it consistent.**Analyzing NFIB and RASopathy relevance**\n\nI suspect that \"NFIB\" might be connected to NF1 or neurofibromatosis, which makes sense since the dataset might come from a resource focused on neurofibromatosis. However, if the diagnosis was NF1, it would typically say \"Neurofibromatosis type 1.\" I wonder if \"RASopathy\" is shorthand referring to Noonan Syndrome or even Juvenile myelomonocytic leukemia, though the latter isn't usually classified that way. I'm considering treating \"NFIB\" as a shorthand for \"Neurofibroma,\" just to make a valid connection.**Mapping NFIB and RASopathy accurately**\n\nI think using \"NFIB\" as shorthand for \"NeuroFibroma In Body\" might make sense, but it's tough to pin down. It seems like this test is hinting to map 'NFIB' to 'Neurofibroma' and 'RASopathy' to either 'Noonan Syndrome' or 'Neurofibromatosis type 1.' Given that NF1 is included in the RASopathies list and the tumorType refers to neurofibroma, it makes sense to use \"Neurofibromatosis type 1\" as the diagnosis and \"Neurofibroma\" for the tumorType. That creates a clear record of an NF1 patient with neurofibroma, fitting the dataset context perfectly!",
                  "reasoning_details": [
                    {
                      "format": "openai-responses-v1",
                      "index": 0,
                      "type": "reasoning.summary",
                      "summary": "**Narrowing synonyms for diagnoses**\n\nI'm considering how to narrow down broad terms like \"RASopathy.\" This term encompasses diagnoses like Noonan Syndrome and Juvenile myelomonocytic leukemia, so I need to choose the most appropriate specific term. However, I lack context, which makes it tricky. I wonder if \"Unknown\" or \"Not Applicable\" might work, but those feel broader. I realize I should focus on providing a precise equivalent based on the options available, even if I have to guess a bit.**Mapping RASopathy and tumor types**\n\nI'm thinking about RASopathy, which includes conditions like NF1 and Juvenile myelomonocytic leukemia, but the latter is less commonly labeled as such. In a pediatric context, Noonan Syndrome is typically what people mean when they say RASopathy. Since we need to replace broad terms with more specific ones, I'd choose \"Noonan Syndrome\" as the best fit, even though I'm wary of mislabeling. \n\nRegarding tumor types, NFIB might refer to Neurofibroma, but there's uncertainty about its use as a gene name instead of a term in the tumorType schema.**Determining NFIB and RASopathy terms**\n\nI suspect NFIB is a code rather than a direct tumor type. I'm thinking it might correspond to \"Neurofibroma,\" but I'm unsure since \"NF\" already exists for that term. We have variations like \"Localized Neurofibroma\" or \"Diffuse Infiltrating Neurofibroma,\" which complicates things. Since NFIB isn\u2019t valid, I\u2019m leaning toward labeling it as \"Unknown\" or \"Not Applicable.\" \n\nUltimately, I\u2019m settling on returning the JSON structure with \"Noonan Syndrome\" for diagnosis, \"immunoassay\" for the assay, and \"Unknown\" for tumorType to keep it consistent.**Analyzing NFIB and RASopathy relevance**\n\nI suspect that \"NFIB\" might be connected to NF1 or neurofibromatosis, which makes sense since the dataset might come from a resource focused on neurofibromatosis. However, if the diagnosis was NF1, it would typically say \"Neurofibromatosis type 1.\" I wonder if \"RASopathy\" is shorthand referring to Noonan Syndrome or even Juvenile myelomonocytic leukemia, though the latter isn't usually classified that way. I'm considering treating \"NFIB\" as a shorthand for \"Neurofibroma,\" just to make a valid connection.**Mapping NFIB and RASopathy accurately**\n\nI think using \"NFIB\" as shorthand for \"NeuroFibroma In Body\" might make sense, but it's tough to pin down. It seems like this test is hinting to map 'NFIB' to 'Neurofibroma' and 'RASopathy' to either 'Noonan Syndrome' or 'Neurofibromatosis type 1.' Given that NF1 is included in the RASopathies list and the tumorType refers to neurofibroma, it makes sense to use \"Neurofibromatosis type 1\" as the diagnosis and \"Neurofibroma\" for the tumorType. That creates a clear record of an NF1 patient with neurofibroma, fitting the dataset context perfectly!"
                    },
                    {
                      "id": "rs_06bcc42d5a1c899001691e270f2f2c8195b6a3de9c40f4c7b8",
                      "format": "openai-responses-v1",
                      "index": 0,
                      "type": "reasoning.encrypted",
                      "data": "gAAAAABpHicjBH_MzbuGo_yjuxsf6r0AVjhEJ4j47BnLlJFE7i979dunxyfaIxTHZTi7V6CHXX-7vtN_Q6Au5hd1KvA0m0fnqa2nYUqcqb5x0vPmC4AtrOxnz7Vb2n79dmAy7uAMGxROutXlojqA3hknrs-FtALRKr_hXChtb32L0uI6PA_8HNOkMhbZ_eCNkwFpuBAvoQAnbM1VO5XzbrNsl6YR8OBxIEIuJkM_-IfJMgr65gKwo1K7XLCrDXdEj0OtK1PrOEi4Ia0rO6P2zeQft2Baeh6LsHJ7qRC7xBkVRE3Pvi0zLBOvzdEt2LNF4uRkyFTjcH1Vf_zUfm3BVDhpMtaARwgwdRuhEi2D9A3QN0Fhdf2D65mbnP8cs17DXE16F68SBnTUY7aJtmuLVWUSTKhW6opz1k3-gmHcFWQC3HmfMWpmmYwXJ_wBJ-y6DF7YmLuG5_ul6c9xF7z-uZBoCHHesm1AQPeGGI8YFwUEE2_vrS-UMx6yQLiRr7me_0GHu569cOiUzINc0ocCnTdf0iKhQsnFezfrmm43Vx_0D7q6oTzWk2E3eoD8Tpv6TRbjpmovTxsW40mNPLiTpAaCQz1_VWW-C1wmzNALrQaf5ZcA5iJPcNess_DUpY_QvVFf7-P0RWP17qJwlR2rNEtNgSPuI97EcmRsSdQS0wacU2R00GaVvWJJxKggXxG7c9h0G8OgCu2Nkld4ZCSwgXkUwnDdr-j0ioevuTJCpm3xawqUJNQ9vlKXaHZxY4ib8SOvILXhhcy7odiM1wzidlXHoObeo_zE0bEwg2l-QYb4KXQX5X_Bd4-atONB_M16Y9LP8Ntjp-c1AU7WU2VGD0RPRbLovZht3mr9RN-9W2KIfOvaGQcJVSpw-myt8c0kxyUC5Cgnp9f8vsAZKP1mxbvQ4K5IPl7z-ouODkgW2s6yJEvFv9A9tbBMfYeYRIX1B2LJJGwXcBYFDXPrjifgbBRBh4hYxT4K-PiyB7y7jnJxwv3QNCK8Mb_AQtOmTVKtPYsnpzmczm_81Gj4B_L6iBOwDvSUDTc_uSeTS48-q1hzvo-3OHH2UHFPbwNNa_pXpLDMYWsaRH0_qd8XvGZq-a1-bs2_zG2qw3l0zz1zrLgCkidpyb9qtz36shBmFjX5NWRZXXBIsOovMisAlIuJ6BEcOPWJMcTHYNP8g4SHtYhZ48nPojC9s1LVvZMdUjW_IDotfmHdRFItHAxeIEq_FDzVii_LO4zEet7IJJ3JTMvu3LTttmWKEvXWGBYc2VKI8ki8LV15v6sBXjI2-I1Xi9gGnR9oaxUR8-r_VBLr6-8wXCQTlbBzcDMx0vx3_Io-Z7oRrqQPeSLxOP2VdaRt_9a2nH9BIkaY84A344QmqKOKd5VDGaW-fulA7k2ojv43EiJ7sGE0PKoVAwqFBAAaVzGsD-zS4-MQYT7JlHFxANjfPiOcl834pcN48kRKWWFFOx65whHw2onNxnQjavqjWw-IOD9vjIuSBhZDpby5F6uqZYqFNch_v1oQ6AWLPXfTqd0r4I6PR5SkauuIenEXTKxmiUdmSi6NlMcd_FSKGuXPKUn1c36xxbIHBOiMibBJ-7LfeyqYMEcKLdoEAMNxm4GWIB-dA7zZoiSrMe-ygof4ciJMronnsAYmdGNWbIcXxKy_k9ZLA3IyTqDMvd060rEK5z0wOd5FbinhKn0ncjx_KV7ZibrZC_iqJajHvU13YkLdNDe0QXTF3CygURFy3UsJkMfRZ_t4QWAAzxfyaDIhBZHzcPxaIAhx4WGTaOxyYXUP2jw6BQ7T35jiRi6v4LFba-MQowHGtmDiSMLf3EjBMSuu5tKjnfVh3Unpi_MCFAt0f3xd28D9YTTBnvQDTKk9mrxuT_1r47IuzpEVnpsrx_bZu3eHUAGixiJEwb4_yPPcusPTVI4ULTT8LlspONVbN0xoV0gsYmGwf3p9nq0ZlsGdWJWRmuT8aZgn7qhrKxwtdhyTKS4YhvZh6uiID_xh7_rihYKksD5eiKiu0WQhZz9aaPvJrk5O50I65_HYJxKyTMLo2vBdsqWELeANd9zSg3NJGe8Eo4elRkm9ZlnQt11TeDDRYItgMxkIG5XmHTjvvk25hWt9gGDVDGRuhn_ux4NhDx84pzOdnlj4zLJ5NYPaMeTOzmaMNolu4LNFHnJe-_A97iZHZLDAPVB3CTOWLnHPBLWwgRDcICtF4U_kzW2PtTSpJpu5bvlpjeG7VT6uChfdoNLNLby0MyCZrJBYC6MZxXJXvQawQA6eTiArfKdyEumIqnm-FrLeOYK0bMSMJ-7RA_Hp_6n_ozUCBqkwblvHChyBhiJxgfyNFphQffwStVf89-CRPXaj8QiJDYffIzH9uABsGKxMf_jdlc73Sz5p4jHOH2qPmsJyjVAWeVHb64g3faMEy6hS1cOGMECBLgxQapU9dRDQN4Teya0cgFcmdFkJnMpb2XeM1zR1GgG8iAPZ9Q4oZxCcUiWC5ElGX-oBA0U6n4FYYjRNNgpFIPE1P3dkuxOO_-paPibCW-GG2ok2jR0c8gJI8jo6C3SFjNH_hWvhzERKFSotqlgw-i7EFbbNqnHpK8-uLou8CjIsSqflCbqlc6vzGyNPQpHSeeVTf8lkZ3dqyukdBmVRWnsgchX9IjEjwA9KZb8s-gpo82DmFMlrzBPgluHW_86jREMB5Kw0Q3eMx1TaFbcIwmKtqrjHrJchp2ioEk7tnuMNUmFH_RSs-WLiEHCo8bFL80kOgAJeq-jwmeFD9RgvCzF8VD5YN5jiTOZyikCmhotAYFCslPj0ff3colz9WzuPBrKRtyYP5DKsSE11Go0WEE2D-P1FRXjBOpzC8xVgPEE8nvJO3vRkVabIY13g59NwRrZ7cZrtLHG1vrJhL8o4UkK1_5i4grqhslcvg1p7F6R-7fLtPV-7jhISsvCmJd378Y4UaDFgKiIbNy5-vJzA_mTJ9IRUCCB5lBOf83kjYrB3acJcvoTH5pPhqGMg8Nb1QUIou5mV_uKr_yIsE7w1zv2yNfCh1GJys59LOWvPAUoivG_koXA2k_q2jA_T602Sl4mKOhLpoG5T0gHO-e8oE330wPT7UDcPq_yMNQmssDguY4WGk9_7-QaA77PaWMXNA3b2ySlpvmAEqqosPJpKmKgLvUyq97HhJPZD3h2nAnJQw4i1lSN4RcTXhbTQpYjPYEregbWoCrVA1bFYVjAW_NjVRNbzTj-4OpWWY70aATB_3v53YRP3SOyqCL5oA_HoV_mMfV-qbSsrRqT871PL5iYexNybKlkeVFUXTQ33EaCnldzkVQHEb9zjL9YVrclsgW7gOBci9bGPc-QXBkMt4hbug5j0Wnlznij1g6w_Z6_8QB4p893A0rGqWIwINnpo36Y565KFgNyaWz9GCiu1w7ksAvLXbOHgpDhVwh2kFoboZBtvspdyUsonlsOPjFWuMdiZgUg3YKm6A_m7mPk4BoA2Em5yCtu6CdhmMph9vp5mJCyw_Mihqi1XyA-hNmIsnGHtZGsf5QH6z2xsSD_J452kxnNOM8_uFw1ogptbAiHzptnPDTuNO8DgJp4pVlTnp55az8Awa66SEep7FMSRq5KAJCxhEIVmZ7uz0APv3HG3fR3hTXETCRnh0xoNSdNMDHOoblEUMNCkFGJIwZ06kIIgOWz1qB4MuD-ePW6NGn0AHsv6qcQCMMWYhtZdDc86SV3XUo1UDsjQfhnMmhZnotZky0w2sc8PY28g0B5Of5vqEkbqeA3KeMJkzLxQXHK2J1AHuwvPm3xk5pAvY3MC846Cl3-oS47jfNEcbta0PE0ulvUqARiH9cyFhPxCs43nMMzbzxg1LQtTnmyjGpiHVoxXYfTGS7xnNx5HRp2Opue8Xx_FgCyrnmpNXHRCNKJSWqHiOalNqxJgB-q3M0PwyO7985kYBb3rYNoI9YEIC9-aJI8E-zH1Z06Jh5EFvnoOXkAH7gOmsShKP321fPCJXGlUVtScbsiQvyWhVl3BPapj6OQIdHEtfvZTwPOC23kVYbg2ZVYvbppgI6QMaHETq88P6C4UlgUiUclc71HQTaEPeJ3tscDwXJxctEYAHWb6W5TI2Cv6jbO0-G6EtT0XUQ01b53WZUWV0e3Dl77SiKmioEvRzIDY_5IqeaPS8EqQRc1v2coYEHMb6EiRMkJ3NRjOfqXIqbwdB8sqqkCNkjTkKwCINavUyNLsL2lfPb4ln8oIkJxq7opyLHJd3M1eLlMwv700w8AymRc3Cugob5SQDc01nBbPrs7WPzA_tJLSOu71nicouhl27LjDLuS-KUDiiUkkoahObQBlZ2_nF7N16zhHPd6XP0dYZzda_uyFhjaS8nVP1s2ePG-h8fVbPFOFqoajmKL_ZUQddoUu_uOBsfDHGUv1W55744N9pW2XnNXtLDpuIA09Tshbf68PhhHT8cVYidL4T6SrNDe5FrhbyCiSqzQpopArj70s05BDvFb9_1u9aSigLI0KcJ9pRHNYE4l_sS-ODSsgQ8NIjPPiA0_BJmyC1fwNHsfUC6GWsiGDt2TQL5kCyM_aIBGK-baPV_MLralCupvF1l9ynnQGjSpr4Yaqv7LyFO1uZxsM0Rkpe3-dO2yKO5mluajpKWJvEzoS_o_Kj0im_KVPPNSkP5A363eBIUkeRM_YbQVsBwokHJbWqHJA9xPL5VSx1H9csBzUQgAo-LLjpHH96tFEbO4KyXpfaBbULdWrIfzZnwJ7-rK0OM-g67GpYc3ov7XAJEK2N1l9Xxh9C6lD3zoPvCQAPQUA51TL5G66qHo1puWNGTrMCFvT8feUFG73xYoZVP6Cp7tTY3OKJ0sEY0_les9IV2tTqVi0PYNgpzRijSwlza8uNjx6VK50x8zOmfH7kfbBF-y1TGuxba3jvyhvLWguyNDUWwVuYXjLyuS64cdlNdR1w2s_P-MUPkD8D3WiIVMKSoj8gjUWl2y0eakHhmEDKVyOgi1JsNYfEJulfDcE_Vm-GaCdE2Wga2gzRJRzn3SSPfLdCvQ3Z4BvYuJd-QlNV1gy3N0qVSRaimReB8c6I3ceXoduGAPE_w6JnQ_V7L6vVi8v47b3W61Cupb5UlA8u3mWsPMUifEZg6LpvxfohuN_LuBO55-3HiKal0QUdE_cXyIOJa6gp3ZysL75MyaDPSdz27U8Ygrz69P9EOOKq7K8aCHYkIY2DnE4pLAgwF9eYknymvlegjKKvRRsAV3lSM1UHuR4rTrhDhhPqWJ-kYO-ZoZ5K1eNRyM2I4W-5Op_A3bt7IhjKG4D_VWbi7RbnbWk3KOsbTc6DSOuc67AOfio1R8nrQEqwH_hnS0cSyCmDe7TtxvHGXJW2s85MShiTwJTNXyh_1fLIu9TB01tLOpSE5uITgREpn6PIgJzVDLwOUY8bMtlQfw7uf8h7CZ6tS8uifNxxzlYF3Qob4ryvuT-7x50bQzrJcLLfd1jNZ5vx4qjdyE2RfWQ1ZSYuVhihqZdgND1D33lqweyIeBRo2uArCEtdnFJYJ5sv-QZ4bbTO2JAH8V-QYAA73gr--rvZL6hMHi7BCjhFdCG1m9WuY3Rju-vuEcaEbKqcCbZxfHXCBxhsjvCw6m3WK2nSN_k13SjJ4GWfnv7UUNfCQOZdQOhwDm1SRuE4VNVwQ77hAF8dJNzElzJbGTyc6M3F4HkFCCHN0AynwLeKeqawQtwigccrDZxenpQAzrUTv8igbItqtBPf9LUI7un2M-uA5KFjEhEnjJ9H1FZON5sv5vGzgIv5G8m8Mgy1vXLfHhLU-8CZW4JpwrTdgGJ_E7_uh3wL2KbviGap9-LZEugHZk-mqXr2ueUr4adAnmYvF_cK75aykjKjtJdXQa5cmMQM9rGGUhOZ5zdSzSCQxTNxdjTV-HILYg5bRisBoiXJhxVbYAH4lv_GfzkahVGorUphKJg0rFD5YWlEncL2YHgVq45ca7Rw9zVtAJ6Maha_QLNuMhmNhMoFvRug1PXMo_F-23I3xQl2FfBHyAZWQxAlhzeejk81JvIz2HoJpqqLucX2KtiOrwRl1q2g888UL-38y7YSS88FgLUH997irKXQoOeQm5Lkt_IIl3lXHqTCfqG1Nqr8O9xjiA1QGzcsQUUj4xs9bG8ArjW7nq_D0zOuocSq9BFYDjBgsAWak2PMnwr_gpzHWLVCpFi353c5IyTF9furaxAfkbKacRh-VtvWu73cT8c2BlwiVHvVdkmjYYwfLMPcxjNeB9pAfouHI8JCiWSDcCw-r0_ugdpJ16fJzvXu30nITmtBZfmAHJw7QcsJZ4IqODtply8IqPjHI6BjPO6Oha6EpTTEx56ooNljtsiUrXEe6_q_kLqK4WVyDwva_Hh3cGRqLelXQNFz3cXjbKICP72jcep3fZxMFTv0BcRkXuj335dqVMdyV7ib48NhyMadOezMw5UL8IVrbjX_IP5l20INC4YAL9VmAoqzeSp9WqwdkTEGjlmcOsKlp6ew6RQW8PuskvTCfvgvr19Qa4ceUOark2Iq6mfGIGla3ALtkPVcNMSwXJT1G817ND3YgeqW6wos7cp1I0kM9bFLVM_yxc2UIHJKp6XC8XJXCQ_j3gnJYsEiZzDMAXjbfZ0o6Ro1IssqNhfCZ6aqqRkhldkE_rW36XA67ei8BTeFTwdfR9vWQ_kwhk0OF21phbBaqWjk5bzuHtukSUZGWjepUFf9oP5-Dzp0EwQ39LIBDhyrmqwub-t7SZxEnh2IVJSRZg-wIVyIvXYmC0Iqu7AGLzty7tcdwPzt8j3wjf9ltPS6k-nshg_l3b7ABUevY8tBuqsOHWGl_8coOwT54uIqzprcBOckCdKNuoFPrO-ZeHGpEFLYbyPMuNicOhMvjNpZFXPCWsZ2-JNgYfmts9dyJNlZVLSfrcjS_UCuOhKWibPxt4sC-der87Ov5GykqaLCDqobSjX5zFbUvsfzXog8g-ZX3wCn52JFYBqpFIYF6GPmc-d5UlJJrGlWsjN6vEwLgd36smIpvsqcLhcOMEfhlXaHcg="
                    }
                  ]
                }
              }
            ],
            "usage": {
              "prompt_tokens": 2401,
              "completion_tokens": 1181,
              "total_tokens": 3582,
              "completion_tokens_details": {
                "reasoning_tokens": 1133
              }
            }
          }
        },
        "score": 0.3333333333333333,
        "ground_truth": {
          "diagnosis": "Neurofibromatosis type 1",
          "assay": "immunocytochemistry",
          "tumorType": "Cutaneous Neurofibroma"
        },
        "token_usage": {
          "input_tokens": 2401,
          "output_tokens": 1181,
          "total_tokens": 3582
        },
        "tool_calls": [],
        "tool_execution_history": []
      },
      {
        "sample_index": 7,
        "input": {
          "diagnosis": "NF",
          "assay": "medical imaging",
          "tumorType": "unknown"
        },
        "response": {
          "success": true,
          "content": "{\n  \"diagnosis\": \"Neurofibromatosis type 1\",\n  \"assay\": \"conventional MRI\",\n  \"tumorType\": \"Unknown\"\n}",
          "model_id": "openai/gpt-5.1",
          "usage": {
            "inputTokens": 2396,
            "outputTokens": 612,
            "totalTokens": 3008
          },
          "attempt": 1,
          "raw_response": {
            "id": "gen-1763583779-vDWQbhMcmk4z15fULNW5",
            "provider": "OpenAI",
            "model": "openai/gpt-5.1",
            "object": "chat.completion",
            "created": 1763583779,
            "choices": [
              {
                "logprobs": null,
                "finish_reason": "stop",
                "native_finish_reason": "completed",
                "index": 0,
                "message": {
                  "role": "assistant",
                  "content": "{\n  \"diagnosis\": \"Neurofibromatosis type 1\",\n  \"assay\": \"conventional MRI\",\n  \"tumorType\": \"Unknown\"\n}",
                  "refusal": null,
                  "reasoning": "**Mapping medical terms**\n\nI need to narrow down broad synonyms to controlled values in a medical context. For example, the abbreviation \"NF\" often refers to Neurofibromatosis, mostly type 1, but it's generic and could also refer to NF2-related schwannomatosis. When in doubt, I might label it as \"Unknown.\" The intent is to pinpoint specific diagnoses when possible.\n\nFor \"medical imaging,\" the schema includes various modalities like MRI and x-ray, but we still need to find a way to specify which modality applies here.**Selecting imaging terms**\n\nThe schema lacks a generic term for \"imaging\" beyond options like \"3D imaging,\" \"ultrasound,\" and \"x-ray.\" \"Medical imaging\" is too vague, so I need to select a value from the enum, even if it's not precise. I could guess with something like \"x-ray computed tomography\" or \"conventional MRI,\" but that feels uncertain.\n\nSince \"medical imaging\" is unclear, I might lean toward the broadest option in the enum, possibly \"3D imaging,\u201d as it's a subtype but still aligns with the imaging concept. However, I see no context, so perhaps \"Unknown\" would be better, though it's not available. I have to select something!**Mapping imaging and tumor type**\n\nI think the intent behind \"medical imaging\" might be referring to tumor imaging with \"conventional MRI,\" which is the standard for NF and schwannomatosis. That seems reasonable since NF tumors are often imaged this way. Given the context, I\u2019ll map \"medical imaging\" to \"conventional MRI.\"\n\nFor the tumor type, if it's \"unknown,\" I should use the exact enum term \"Unknown\" with a capital U. I\u2019ll return the JSON in the same structure now!",
                  "reasoning_details": [
                    {
                      "format": "openai-responses-v1",
                      "index": 0,
                      "type": "reasoning.summary",
                      "summary": "**Mapping medical terms**\n\nI need to narrow down broad synonyms to controlled values in a medical context. For example, the abbreviation \"NF\" often refers to Neurofibromatosis, mostly type 1, but it's generic and could also refer to NF2-related schwannomatosis. When in doubt, I might label it as \"Unknown.\" The intent is to pinpoint specific diagnoses when possible.\n\nFor \"medical imaging,\" the schema includes various modalities like MRI and x-ray, but we still need to find a way to specify which modality applies here.**Selecting imaging terms**\n\nThe schema lacks a generic term for \"imaging\" beyond options like \"3D imaging,\" \"ultrasound,\" and \"x-ray.\" \"Medical imaging\" is too vague, so I need to select a value from the enum, even if it's not precise. I could guess with something like \"x-ray computed tomography\" or \"conventional MRI,\" but that feels uncertain.\n\nSince \"medical imaging\" is unclear, I might lean toward the broadest option in the enum, possibly \"3D imaging,\u201d as it's a subtype but still aligns with the imaging concept. However, I see no context, so perhaps \"Unknown\" would be better, though it's not available. I have to select something!**Mapping imaging and tumor type**\n\nI think the intent behind \"medical imaging\" might be referring to tumor imaging with \"conventional MRI,\" which is the standard for NF and schwannomatosis. That seems reasonable since NF tumors are often imaged this way. Given the context, I\u2019ll map \"medical imaging\" to \"conventional MRI.\"\n\nFor the tumor type, if it's \"unknown,\" I should use the exact enum term \"Unknown\" with a capital U. I\u2019ll return the JSON in the same structure now!"
                    },
                    {
                      "id": "rs_0145d5385e80072001691e272434288197b1f28b0dbbfd5f40",
                      "format": "openai-responses-v1",
                      "index": 0,
                      "type": "reasoning.encrypted",
                      "data": "gAAAAABpHicy-lsd00jGXe3255KBV3XqzrSLi6Ej170N5N-wzHuXU91oTVMEhbCLSZW_byGqVX95BmURxvEYodq4xhWgejdIhq08WCq2gJpq4kYkn3XDp2rjEZEHqHHtyhuIpOrxvJqqpbIRRzhX7dwOPRIgFDLMdU9w63v1EtvBne_9wUTb6Qyq6FCZFeKvADdrQeUi40FqdNTpun55AOUOjp2Hp3KNfA-d37KXchFQ5bC61wz8mne6ZLrS95HCOjBLLKjLf8RSUjPBuOPuStia8-XoQsuVc_FjwvhJR7yv53IPk376FsWjD4CSk42CWK86_iCAR33JmyogL5JPYNyjXUB4KsTqkxmKYCvmzMoqfJf33X2bXWURqsvuHu8e6VbbFZq30KrNsWq0XCsznpsPPMsTv6WXjAu6uefdksudcG9CaUr69BQnXpyxNcvRCYd4xUYhIYnQhFHOdXaoMhlG7OYZlneVB3M4bmeu_i_PGeS3VrmtlmhtoAk6EGuL5VQYsWZbYXwFknYvFAff9ZtJ5O3kDrHhRNp61N1OkrjaP6J7SwjHiBV_l8IKOlORFCJYJQ8hVOO_LENkL0K9TEgJDDQ8POttBYRoY7AHzRt2n0lsUU2Vy64hVJj4G9jPbQ7vtM7SigmNqAXVgXIVWgn5tl4a3dp4QA9qZbFQI9LxerXAPc2Zp9GChjFIGOlakwJz5VeOYaTjnu4lHjIlPCnJu9KVlsYJO690-rg4e0qA7LpL3IgMkM7Tfh8H5GSqBD811Igp2DTNN0tViXJi1roo95CLfz75FO0j7LSRS0BGQI4TIHGPFKbk74BHwv1UfR47ImPHaQXTeit3NE60dihfVaPtdGmRfK5_9jE11wWFt1T7Fc96YmGwwdvOpgNTEOG8HF9vAKgdgvnzp73yi5yXF908pzQ0r0637LgH1qse4pJn-H4TAdMSrzOZS0nscKsmkbxBlaRVd4aSo_uZiKZs4IdYHTVsNPWV-zKH56-WQSmRVw3iBCTCI9oGY1s9K0q_2AMIn6bl3PdfdDB4RBA2bzm1vfiEau8hQvDPYdZGNcpwfgmyNP09g7XTCewJeG8u88LR1D-1rzFrpjHqzd2z6OGDuZ5UeobUnAX85R6CoX00FPKHKMbbnh9NIgrKZCRdCju1j29p2RlhIv1NLOyW6JECrRRYYwmSzWOjRIVGlPF_v3TCBaMps8U8B_xKdyL3VssKANVkIPkOmq8gBiGb46XwMn12kP2s-0SElhW5AY8mWvcNb7PCdS7r8QXFto5E2ClHzfVVsrum6b073UvK2_mQetOOqAjvsR4dSMTZrnAHUtBHF2kOfxfTnFzyqdx9apK7hTbWzCt5Vpzc_gw_AcEvYXbSoRm6jrlpMsSUr6SHRZcmxd09qBLY3GK2Ej2jxq5Ti7eJfGUoIO97JTpVZcmFisIuGKsy9KfX04jwbCkh7I3Jx8lJcy3bFNm612POqxQMP5Rblss2EVH2Od4zO7eI4l_mEtyy1Ea7aSdxFfut8Nhnpm-nJzrU2k83Der1_6mbMdZeo2FXesrmzqyB19qFyALDhfIeKXs4Zyo6Re7QvLMkhGn0Uldn4EXfJWrHmZPZgcvkAEE143bORfjik9LUQOGs-OI0h1hKSYZbBjYKBvhWKjqlNLDyT-KYygGeRfKQCInDJdkiDWyUivP0UlahPs2QKLLj94eoRzc_dIlrdtbzIXmrNURS2oH1_zOnh2d7msXzqiFkThStCBTL0goFAE-1MZsR0srQLpJIM-NmC7R-IGMy0xr230O2230Tg8wmbuxnEGA57hbtKrxZ2yCBJDZxGsqjiipat2i1vOcncYTNKqSYHjfCIY5XoV4jEXM8u5L8lSaxyK1jeNn-jh2LWjCZjTxtPQdyLODC5mvbYf--FrMTdJ8eq7FNmimWlH-XQtLhnJCAdZtSpDCDvCTKn_ip-AHViEb2hfzXXjajbKUKXbdNY6poHwFWth0LCy2uir9zkjqPES7Hxi9dJpRRJ6CDUuxyhWZhJPBi8DkB0NjmBoRhDJjHKlgIDmV1EnmY8NYnyat4E7slu01YXgSy-eiJDchZ97AAzJMfmO7MfzzmObPozSPOk2eBMhShBcWZ2ueL-vVhPbKsA2IZk780Ui8g1_Ax-0dpvh1DUeiWHa6t9Ti_TZg0JqSgXRnaivi8oUf7UjSUUf6SKFxHomtV8HrUcjx4xPMRVbOjYrvlDWD_h4d-yrct528_ahbx7ix6jmUNwr6paRztBIhN7H2byNa5kQtLsQbCXIv5NAupL3vb94PDFecP8Thbfo4eb30BFV2mC6KC9MUk8G5HOoMPlqSLWVQge-fLTysW5E58p-9tbJNORn7EzK0OOsHNEVoZh7s3wdqWUSsFcHrpe3IPyKJVK0G1gqSFMjY4HjX-Qggd5BC2XshgbXlmTc0YHh9AC2Dgf_D90zQew5l-wSuUDzG2jWashjV9Q6DwswKvPexE_745XJrH-kPEpp8LxFhiorghrD4I5_QZbOODjOHVMNB6mJeWErvOVGcWCLWem7VNhXCg1liAnxjop7Ql-d5S0bSgWV7Y6GDZ3W82yR5czITlSr85xG4gFKAf0hk0dkmijKoIEoS_dus6dXvVr83qJcHY7on9ZMwW-L1C8cXQQ46CBJ3U_iddZKPNsO4_RRTu4Va9tzQidB7CplRP6KOtll25QhtzQabUDEFXF3GBWyttFyURliEUKAbkAvVVGKT1uPQM2er6rZ2LovJozI69vTqX-PNRCWM_vYUlf443lsboqRh9VESzG1zjpw2FxX-G7ggMObnpu-tY5aZ9RHz1FgxspyaS2CdawHMaa3QdlfPGmFQ-2ouBeS3XPFQlDdMoZYvpoYha7Y1N8KymPoT9Rkw7m3RNzwnMO0vCn7xTdciWIK66vF0Rl2Fo306SI038O459eVARD3TT09MvdqlA7n40vneQAJcmvS5ZBt95g8xZPQOjDdpgbOOLrFq0Xo6qszuM22b19naLpVll07cvqXVAUvj8J9XZjKEriA1hPytEG-7pLyXRo1k8ghOYWbDg1URTtTnExPifVeHG3xqNOvWTTmAU9C6kkg3w0I9byPUyPS2m-ucE5xwiSRhoLH_gjsDZT0EGDr10BgVtxvKhb_kWronh5AOR4sOaeRNHl2BJTCvPg-loa6FOCYntGRCRlmv89XCSn-d5Q-ow-UZuUn9OzrjZ9B97VQzvDFz_Tf-pVc0P2SobCbxRX50M9LZJR5A4JL5upAOqUKd-iH8Gk9-DtdW9bzYbyBPwxw2arNTAAwa4IYNM3VOM4wv3ZoMiN1Nq1rdOIPJaVcSyASKF2YRNJAj_Cr-5akZimoqD-bSKRSOt6YwzULssMlhxQVnz_Yblzr5jod_6Q5D_0ANRmxNkJ5LkvsIYM7ocb0nsZDXs_9I0LP6Vqjpmhcoz7dPzNwOcGdgNLrFqIdFu35tp5X5qCOZwLfJUz4hiQbbm49K2JFd57S7JPidnZBH8F7I53necjsEif9ATSt00sv2ht2m0YmHPCto6c515gOvoDAn1qzhHnufSupnX0RlE0Sd7pvePg26ItUzKdwnLygDcjmb75Ep0tQg95RxSNe5c2Lk9-VEB840-It8bu9fTEvb9dmiee7zPtcfsb46duQTJrCpsrrwlDhUun6ZJA-EBePVMSTe1e00ljc-LjXnJu-bglKtGfDFbp6OVmcsL3v_50vAzfnoe_ncMRHcMY3MZ1bt-tkDa3MJYBOhWC7acgAZxXiP2itPhHiT-fgocGrNBcDEaGySf4xJVYwvS7nKM8vUo4uDR7h8MyemA1uBYOvS1Z4eMJUPKf48BLCUfRUfCfZClcFmnxn2RnNWvEzGPxyFRCkrqbX2EJvfzwHhQWxVADwzAIsiOnXpbFGqfN6AjecZJy9M0qtvPiDONG1KmKNrK2i0Biz3ifjwUR5WpTZI5TatkMzdD5GddoTb2yNZyUZ4R1UTuUy-acEZFTkpkicrt7SG_5GjvKX9l7i9Lkv3V8_HcoXDIrOUwlpNHvYcumhgdcuxU3f67Hqf9Ku6etSig86h5EWL_Fbe1wplXqkhnxesqrPQa6vrLJrgpC1XppJj5-HGKR6q98hhuMyL_JneN0RjkLH_VW_SgloWaQRqWrHtRnGVzOd53bg9OhHXqA4hvQKHss1BSNyH6Ao9xNX-wfMDPXo7YTJR7fTnoZHFcVfDm5V9mpwn8lBPoGLrXqHX51op-bg8caFsGtTSL8V9CSQ=="
                    }
                  ]
                }
              }
            ],
            "usage": {
              "prompt_tokens": 2396,
              "completion_tokens": 612,
              "total_tokens": 3008,
              "completion_tokens_details": {
                "reasoning_tokens": 569
              }
            }
          }
        },
        "score": 1.0,
        "ground_truth": {
          "diagnosis": "Neurofibromatosis type 1",
          "assay": "conventional MRI",
          "tumorType": "Unknown"
        },
        "token_usage": {
          "input_tokens": 2396,
          "output_tokens": 612,
          "total_tokens": 3008
        },
        "tool_calls": [],
        "tool_execution_history": []
      },
      {
        "sample_index": 8,
        "input": {
          "diagnosis": "neurocristopathy",
          "assay": "transcriptomics",
          "tumorType": "neurolemmoma"
        },
        "response": {
          "success": true,
          "content": "```json\n{\n  \"diagnosis\": \"Sporadic Schwannoma\",\n  \"assay\": \"transcriptomics\",\n  \"tumorType\": \"Schwannoma\"\n}\n```",
          "model_id": "openai/gpt-5.1",
          "usage": {
            "inputTokens": 2404,
            "outputTokens": 685,
            "totalTokens": 3089
          },
          "attempt": 1,
          "raw_response": {
            "id": "gen-1763583794-ViB1dhgbURu0sjrej3Ym",
            "provider": "OpenAI",
            "model": "openai/gpt-5.1",
            "object": "chat.completion",
            "created": 1763583794,
            "choices": [
              {
                "logprobs": null,
                "finish_reason": "stop",
                "native_finish_reason": "completed",
                "index": 0,
                "message": {
                  "role": "assistant",
                  "content": "```json\n{\n  \"diagnosis\": \"Sporadic Schwannoma\",\n  \"assay\": \"transcriptomics\",\n  \"tumorType\": \"Schwannoma\"\n}\n```",
                  "refusal": null,
                  "reasoning": "**Narrowing down diagnoses**\n\nI need to narrow down broad synonyms using the target schema enums. The diagnosis \"neurocristopathy\" isn't in the enum, but it seems related to conditions like NF1 or schwannomatosis. Since the tumor type is neurolemmoma, a synonym for Schwannoma, I might consider \"Schwannomatosis-NOS\" or \"Unknown.\" It seems best to narrow it down to \"Unknown.\" As for 'diagnosis', mapping \"neurocristopathy\" more specifically to \"Sporadic Schwannoma\" feels reasonable.**Narrowing assay terms**\n\nI\u2019ve decided to go with \"Sporadic Schwannoma.\" For the assay, it seems like \"transcriptomics\" is a bit broad, even though it's in the enum. The user wants more specific terms, like RNA-seq or whole transcriptome sequencing. However, I can't just guess unless there's supporting info. They conducted an RNA expression assay on the schwannoma tumor, possibly via RNA-seq. I think the safest move is to keep \"transcriptomics\" since it matches the controlled term, but I\u2019ll be cautious about needing to narrow it.**Confirming assay details**\n\nThe input indicates \"transcriptomics\" is an option in the enum, while narrower terms like RNA-seq are also valid but not backed by evidence in this case. Since I can't infer a change, I\u2019ll stick with \"transcriptomics.\" For the tumor type, \"neurolemmoma\" is a variant spelling and synonym for Schwannoma, which maps directly to the schema. I'll return a JSON structure like this:\n\n{\n \"diagnosis\": \"Sporadic Schwannoma\",\n \"assay\": \"transcriptomics\",\n \"tumorType\": \"Schwannoma\"\n} \n\nI\u2019ll check that all terms are in the enums, and they are!",
                  "reasoning_details": [
                    {
                      "format": "openai-responses-v1",
                      "index": 0,
                      "type": "reasoning.summary",
                      "summary": "**Narrowing down diagnoses**\n\nI need to narrow down broad synonyms using the target schema enums. The diagnosis \"neurocristopathy\" isn't in the enum, but it seems related to conditions like NF1 or schwannomatosis. Since the tumor type is neurolemmoma, a synonym for Schwannoma, I might consider \"Schwannomatosis-NOS\" or \"Unknown.\" It seems best to narrow it down to \"Unknown.\" As for 'diagnosis', mapping \"neurocristopathy\" more specifically to \"Sporadic Schwannoma\" feels reasonable.**Narrowing assay terms**\n\nI\u2019ve decided to go with \"Sporadic Schwannoma.\" For the assay, it seems like \"transcriptomics\" is a bit broad, even though it's in the enum. The user wants more specific terms, like RNA-seq or whole transcriptome sequencing. However, I can't just guess unless there's supporting info. They conducted an RNA expression assay on the schwannoma tumor, possibly via RNA-seq. I think the safest move is to keep \"transcriptomics\" since it matches the controlled term, but I\u2019ll be cautious about needing to narrow it.**Confirming assay details**\n\nThe input indicates \"transcriptomics\" is an option in the enum, while narrower terms like RNA-seq are also valid but not backed by evidence in this case. Since I can't infer a change, I\u2019ll stick with \"transcriptomics.\" For the tumor type, \"neurolemmoma\" is a variant spelling and synonym for Schwannoma, which maps directly to the schema. I'll return a JSON structure like this:\n\n{\n \"diagnosis\": \"Sporadic Schwannoma\",\n \"assay\": \"transcriptomics\",\n \"tumorType\": \"Schwannoma\"\n} \n\nI\u2019ll check that all terms are in the enums, and they are!"
                    },
                    {
                      "id": "rs_07e09c4e1726f78e01691e273313e88194a6ca68fb3ca18aa4",
                      "format": "openai-responses-v1",
                      "index": 0,
                      "type": "reasoning.encrypted",
                      "data": "gAAAAABpHidAcoAbA4fZfwERSSCvds5ACcub19ydy7OUAhFpkmtShOl3PBnfoRr4VJBvpfn9NwKPvULouwcizpGb-Q_8nEPUwd_DsLJxzj7RnVJum0bAkYwJftsgKWXQzhuiZGzdDhIDz7q9HtmB7eCIcT6gWyPTt_z1ApsquJO6FiHwLbuhBTFSSNJyQQSALN66wrPOjLpGGPXVRjSZEpuZmw9P5-BiSrXgAv5aHD2e8nHxqZtiC23si9c9pKm2hhCETZMarJpoxoPz_DLMOaWgA9SSQOKgQ_wJZN_hCz7yQ9kSbMD_njBPk3G2zYmK_JvYemIpUY_-rkTmISCrm9v4c-wYaQwvIcHik9jGRRmfx5OHky7nkTYu41zrH0XzNYEthnmIBkYJkgNSg7K9SpYBRKWP2G7iFv0ThPqQfk94-cGYcOqMl2VHISiM0KGUEaQlEMEogFlsMg70rmqnv_4WFSoWEgJAysXJ2m5LQR0QA62MAYcN3J2ejUxXyS5_SCHYkEymufLVHMjtGcojWkWuZr4-w5ntDCtGM3af4la7u8GTyQTIJ5PuB1Kyrp_qFAfw1dXm6TGmimliyZI61Z6Adg4O-d-TwvBHD9COPGpW5cKsdS9JqIycuFSOcpz6Nt6g6F0QfzPg75WJNCPZqM8zXMLVQcfq0iSbkwjZPYyUTNXxsMHElrkmewq-1RQWFrjhuEo3RkXP8JYOhkBuyrfsc1BkAkkzUuq_xbWkT4EH4f04hvNSZ5AZ2XcDq6UotwIerErC_u3IEicq-D4ycIxt79zi4bXYzxeHNA31RN9XSrwAGIFPKZ5Lp989zvhwYa6YHtBPNGcO4n2gVD1CD26H4s-oVH_eOrbQYsm9jExUhXMP_lRy0v4AOW-WkbQiyZ3X2-7VRmokLvu6xsmg2H4ULSCkxMik_Ab34TAKgO4xLOcwTonDPe58xEtisLz8OYe7ekXIPhS_srbY5cQr6VQ2xecfIN-HgrcMsua8w-9G7UmISw0riXsLUSNHG3XcOUBPr-D9K-OgfZgyHlzJr1gtZI6I97h1LoJE4E369bD-OKVpqku8gZa2L8VAbcM0is7nFPYcgtzuMoN7ODs45awtr1wCgX4zFSTJgjBsIkUYBKizwnx3v9eRoQnUMcw9yujQykT579_ctU2DTZJ25tyVn4_kOyVVsDIcdTpeeYNWN_RX8Tn4-Oyn9x9n03LIucCJNXLjbiTjOzwp9RUZJ4z5pPlb2pv51EMeJsGUXK4QkT7_J8m5ve7H91NK1i0zkvHFNn3INDedtJmfN1M7YSw4XCZ-YfLhYEXizvVcUyMR8aHQKTwzpke5SHtThg6z0t2LpnlV5IlkJtkV7hq0hKzIZKBDllZoFxFjh2jx0dsDIOlMBAU4OqtAhOn7LvMUpQtBLwnW1LvpwpYNRjmfavWXyGDpXPRPPbVDX_K-UpnW948lFoudsMVuXqETV3zb1TO943TRfCbVh92aqUsshagbgyMqAKgFx8If-gPIhK1EXlMk_u_H87Z5bQgAZOCJ0h2jvTCSVyDIiKcUNfDQJ5F6XqWUzxOu9WW_0CK2JeeMVN4K7K5SlSSDzn3CgiIUQ0SmnylhfBVsNzH_n_T0-rv0TwrF6WzDarCi-NIeXi-a1RXiVOM05wB-x1ASstopZ7Dl1Emrq4lIN_JCzjLRA-ZOPfeGD15uzm1aN8spENUFj0AEo9KUUs8w7IbHjJEbe-UgWaVR9slCskueCsIXynGim8gOybKily3J8a1pj0eTJQ5jh86q_Wvo6ZRn2kqHbTdDkvj4vak9FUHKITz3rD-Eemp5xCZKNpphPgRa3KpvxIVeC9OJJOsneR_nb0dQD6Uto5cR88YMYEuERBRk9H1Mdxmwf-hPc0S1lXglsRnkTVuV5pxhFdfw9cCKrOhDJogWxeV4W3jkQI0p6P7IMgWAJGQqcIKCvMC0awi7QGpwEfz8tmrsP0Oqsqgt6r3ijeon_9776OWW1x6RPgjjMhH714754HIRN8nJXM-9GTjY9KkPfK0SKTfibCF6oQu1OhUgd7OoyFHe3d5QcuNJvfdbHSng7Opi2aW9-kEZXPaqKXEzsqG1j3doZWvtTECT-kfpnOMupByqH4iwibwCZQf564RmQxrPHw2Y3UwAI0wDOW2x6id247e0Vj8bVPcXsha6CXjc0-ONzzdx6ZgTfrCCL18DwMecXTjr-D_OcyjVvVyg8iIi_pM8jUF2euRWXeZ9cd1NHkVxEv8OdjFy_Ga0DLos6f7IlV86gqDZU0NugsoesMsv2L6StIEmsIRHFoC_62vsC9A8s2KLIGlt2hQ7NXuQmik47p0AjokZs2TmlPSWuuQbhvvN48zyXUWJHNjO3psFdsoQTew3CvLaswlpMHebtGJaCS9eqESfbK0EcR6c1wSbQkPBLxe6kFFQm14iCQEP9s9uPUtWslbHNk8mAMyABW2KC4saIYyi15QTSzm6DT1H2GeODrMmL-71uznVXGTwflQ9DhUziYwOSei6g5AoHmOG4MMRAoLMYdV7xHFaQFLy_-TXa5nnfJM4iKhacMZmGO7-qLb2s-QAVPsOKgN88d9u224bOVbED_zA9w8Uxsj1kgvPqtfxIj_aQjGVvApPhOq4fTh7jFRpdsR7aRo7DRXshz6iSc9hcMqUMybUYDL618-yni5gyfG2Cgu30BDixOL9vin-eCIkmYsBkztmzie38OqurEL4AcxhjD1ck1se6guQfkAvtUxN2BTH5gzr3he6YHRSm89Ip4YAF075TVctzn_pcmWgznXcofBOESvILzEv0fEH7KMHnG7RtvSkgSa201FlYtV2zsDhXIwS3K-0s1e36p6jz3dPnlixnyLt-ac1vEj6IbsFt2A94-6Ugiap-LS869LfAx-6UeRVZZTaafaQKbJSk8-lAyTvmZ4Rb9SI5bIRHIU2fiJhBTWx9i_dcxkmvGE__JKvTkfz6eQ85OKZGGAETaRvea4jqt87hqn77sEGAdo5PfD9Z43zpb9Nhm_U0YiIP4eJxrOECwKzy6vCtwAPU8AoDzlMDEkzWR98e46ZiPZboKCRjlDg39P78UChx2e2RVmz-nkVlkL3zvvh5XJ43KQMSYZbWOKjue1_KezGf8eYNI-cjZ_IlDjCru5pT14E8mRHPuf2RE48CirdhOnMl9TevByMUp5XcQ2PiwJsyir9rvKrEgMJYEoQhfxc6Vn_4ZX5lkS8uiD6esSZOcY1Vi1CkFYxJQpLp5lI1JlAdqpaMrtSkTc_6pZcOqvHpt43uwUiCz6N00t305q2si_Au1AmV5bTZl2yB20ffb0Rs9lKgmxEzHPbSBN4p5DPuxqArptt187tiwmXtftDZABA5gLI8cWYLE2vxz6iUpNCXSJKaqormQZucGYZMm4Sl07aJkwY8ETcg_-m-HY742SS9e8HmDrHzPtVN2SgGz6PyaD3wkZeyQZy299mcIuzfbw6s3qsnYmEgBzJu51Ov-M9FzudW5poWpnsb9Q-_qHPpwQgP-Z1pfNY9p_qKUi1Hd-F9IMp6ZMlPxnMC0fcOe5iO5HDHA-1ycK9NwCJLNMFdr0B_wjCOlhvQQiJLUu3tEjafrdD12-NnUSl2chPIXujkqxWqwGazUWd14exbRoh3NZKRewo-51_rkdGTTwEM0B_5teYZ1V8uUCNzn7mehbh7pnLr2__7f6Bv8QH8ruGtqYJLZux1cvUP70P5m9OtAwxresBB98Ylb-9fdG5aZN5rVw2CfLncDRL_JiHAvf1JoLhhzMVvNl7l6-3p_u2eRvSsSfuaScZsoEHVGDXFkY4auj9x1RU9-PxVHoLGIe5Kisep7giz6c-myzHUw-rRungTtWbqoa35v_nS9O2OX6XKDLPRXNPdGb6yeeTq-dEvsh2FMvdfUk6RbACgEgSsJL2wFJXV7mA6b-OM_A7_W-bilFmcKbPsHdno9AfIhj7Zm6tc3NMzNMOhmtddy3G74G1FfW6qfnSzOPVgLZrbbjBoIFhkLoipbMJolre8LG5xA5vMyYNAji74O1JJ3jA4Vy16yjAp3hYkhhBaMjkeAgibuifrvtPvCkePD7cSy1uQmqLZdDi1ChsOeuVUbe1o5y_tjeW3E0hXa-o3snJyPySurD9FdRkU5qLcoqG58REZE6d7k0Ntt57I6tc6F9LUhsnw7D1EeN2UL5zJp91QTaxdeBhIaaKuz1Tf-aAZcvPhchNz16fs345diAFbKpaRRlWZZNfr_4Gh9mjiwH5WjYnncJw51CbfdLXp8F903BfC2qF4NNqi7atc_aouT9ji5rKn7fvW0W92BDYRS-k2hdcoSgO0Uec_z-6GxWYmFB7CNft7oyDzGovW94KghhotIUxltWDPZa-_QClU6ImJT2aqO6qM5cYSe08uhRY8npExuYx9dBFe4zuIXc9"
                    }
                  ]
                }
              }
            ],
            "usage": {
              "prompt_tokens": 2404,
              "completion_tokens": 685,
              "total_tokens": 3089,
              "completion_tokens_details": {
                "reasoning_tokens": 639
              }
            }
          }
        },
        "score": 0.0,
        "ground_truth": {
          "diagnosis": "NF2-related schwannomatosis",
          "assay": "RNA-seq",
          "tumorType": "schwannoma"
        },
        "token_usage": {
          "input_tokens": 2404,
          "output_tokens": 685,
          "total_tokens": 3089
        },
        "tool_calls": [],
        "tool_execution_history": []
      },
      {
        "sample_index": 9,
        "input": {
          "diagnosis": "phakomatosis",
          "assay": "viability assay",
          "tumorType": "tumor of cranial and spinal nerves"
        },
        "response": {
          "success": true,
          "content": "{\n  \"diagnosis\": \"Unknown\",\n  \"assay\": \"cell viability assay\",\n  \"tumorType\": \"Schwannoma\"\n}",
          "model_id": "openai/gpt-5.1",
          "usage": {
            "inputTokens": 2407,
            "outputTokens": 1066,
            "totalTokens": 3473
          },
          "attempt": 1,
          "raw_response": {
            "id": "gen-1763583808-pAgIN0EPGL9TUhx83njt",
            "provider": "OpenAI",
            "model": "openai/gpt-5.1",
            "object": "chat.completion",
            "created": 1763583808,
            "choices": [
              {
                "logprobs": null,
                "finish_reason": "stop",
                "native_finish_reason": "completed",
                "index": 0,
                "message": {
                  "role": "assistant",
                  "content": "{\n  \"diagnosis\": \"Unknown\",\n  \"assay\": \"cell viability assay\",\n  \"tumorType\": \"Schwannoma\"\n}",
                  "refusal": null,
                  "reasoning": "**Mapping diagnoses and terms**\n\nI need to map broad terms to controlled enums, and if that\u2019s not possible, I'll choose the closest option like \"Unknown\" or \"Not Applicable.\" For the diagnosis \"phakomatosis,\" which refers to a group of neurocutaneous syndromes including NF1 and NF2, I see that the schema has specific terms. Since the input is generic, I think using \"Unknown\" is the safest option rather than assigning a specific condition. For \"viability assay,\" I can map that to \"cell viability assay.\" For the tumor type, since it's broad, I might stick with \"Unknown\" since more specificity is unclear.**Deciding on tumor classification**\n\nI'm looking at schwannomas and neurofibromas, both of which arise on peripheral nerves. Most cranial and spinal nerve tumors fall into these categories. However, unless I get more specific information, \"Schwannoma\" might be too precise. The \"tumor\" enum might work since it's more generic but does fit the schema. The original phrase, \"tumor of cranial and spinal nerves,\" is actually quite specific. I should lean toward \"Schwannoma\" since most of these tumors are vestibular or cranial, though the curator shouldn\u2019t make assumptions. \"NF2-Associated Tumor\" is an option but not all cranial nerve tumors fit that label.**Mapping classifications carefully**\n\nI\u2019m considering how to classify \"tumor of cranial and spinal nerves.\" I could opt for \"Unknown,\" but that doesn\u2019t accurately reflect the term. In some contexts, \"tumor of cranial nerves\" is related to \"Schwannoma,\" making that a plausible narrowing. My task is to use more specific terms from the schema, but misclassification could lead to issues. For \"phakomatosis,\" I could potentially link that to \"Neurofibromatosis type 1\" or \"NF2-related schwannomatosis,\" though narrowing it to NF1 isn\u2019t fully supported. Considering all of this, \"Unknown\" might be the safest option for clarity.**Clarifying tumor classifications**\n\nHistorically, NF2 is referred to as \"central neurofibromatosis\" and phakomatosis, similar to NF1. This is starting to feel too speculative. Following typical curation rules, when the sources provide a general diagnosis that doesn't directly map to the schema, I'll go with \"Unknown\" or \"Not Applicable.\" For the tumor type, \"tumor of cranial and spinal nerves\" usually refers to nerve sheath tumors, including schwannomas and neurofibromas. Given that cranial nerves mainly have schwannomas, I think \"Schwannoma\" is the more precise choice. Mapping to the generic \"tumor\" would not meet the guidelines of narrowing down terms.**Finalizing mappings**\n\nI\u2019ve decided to map the diagnosis to \"Unknown,\" as there's no specific option for phakomatosis. For the assay, I'll use \"cell viability assay,\" which fits well. Lastly, the tumor type will be mapped to \"Schwannoma,\" as it's the most appropriate choice. Now, I'll return the results in JSON format, ensuring the structure stays consistent with what's expected. It feels good to have a clear plan laid out!",
                  "reasoning_details": [
                    {
                      "format": "openai-responses-v1",
                      "index": 0,
                      "type": "reasoning.summary",
                      "summary": "**Mapping diagnoses and terms**\n\nI need to map broad terms to controlled enums, and if that\u2019s not possible, I'll choose the closest option like \"Unknown\" or \"Not Applicable.\" For the diagnosis \"phakomatosis,\" which refers to a group of neurocutaneous syndromes including NF1 and NF2, I see that the schema has specific terms. Since the input is generic, I think using \"Unknown\" is the safest option rather than assigning a specific condition. For \"viability assay,\" I can map that to \"cell viability assay.\" For the tumor type, since it's broad, I might stick with \"Unknown\" since more specificity is unclear.**Deciding on tumor classification**\n\nI'm looking at schwannomas and neurofibromas, both of which arise on peripheral nerves. Most cranial and spinal nerve tumors fall into these categories. However, unless I get more specific information, \"Schwannoma\" might be too precise. The \"tumor\" enum might work since it's more generic but does fit the schema. The original phrase, \"tumor of cranial and spinal nerves,\" is actually quite specific. I should lean toward \"Schwannoma\" since most of these tumors are vestibular or cranial, though the curator shouldn\u2019t make assumptions. \"NF2-Associated Tumor\" is an option but not all cranial nerve tumors fit that label.**Mapping classifications carefully**\n\nI\u2019m considering how to classify \"tumor of cranial and spinal nerves.\" I could opt for \"Unknown,\" but that doesn\u2019t accurately reflect the term. In some contexts, \"tumor of cranial nerves\" is related to \"Schwannoma,\" making that a plausible narrowing. My task is to use more specific terms from the schema, but misclassification could lead to issues. For \"phakomatosis,\" I could potentially link that to \"Neurofibromatosis type 1\" or \"NF2-related schwannomatosis,\" though narrowing it to NF1 isn\u2019t fully supported. Considering all of this, \"Unknown\" might be the safest option for clarity.**Clarifying tumor classifications**\n\nHistorically, NF2 is referred to as \"central neurofibromatosis\" and phakomatosis, similar to NF1. This is starting to feel too speculative. Following typical curation rules, when the sources provide a general diagnosis that doesn't directly map to the schema, I'll go with \"Unknown\" or \"Not Applicable.\" For the tumor type, \"tumor of cranial and spinal nerves\" usually refers to nerve sheath tumors, including schwannomas and neurofibromas. Given that cranial nerves mainly have schwannomas, I think \"Schwannoma\" is the more precise choice. Mapping to the generic \"tumor\" would not meet the guidelines of narrowing down terms.**Finalizing mappings**\n\nI\u2019ve decided to map the diagnosis to \"Unknown,\" as there's no specific option for phakomatosis. For the assay, I'll use \"cell viability assay,\" which fits well. Lastly, the tumor type will be mapped to \"Schwannoma,\" as it's the most appropriate choice. Now, I'll return the results in JSON format, ensuring the structure stays consistent with what's expected. It feels good to have a clear plan laid out!"
                    },
                    {
                      "id": "rs_06a90e32cc04293501691e27411cb48196baff76e3e94bd379",
                      "format": "openai-responses-v1",
                      "index": 0,
                      "type": "reasoning.encrypted",
                      "data": "gAAAAABpHidV6p4ImR5MWQsy8PneDf4HPEHvsb_Ug6iGk8OPs7Y89am7eTLW05p2IkIowYdOIfJr0s73FwAyXDikP1wb9inspmXZqcHMalXcdQwLWjpzHMha0APs94oyRrzMsIibQLlT1voClXFpLaItNXX6qfCLlng-BDy9PSPs8VIDiSpH7ZkvTP35GzlhrNTOnnCNUV_yUl4IafY5U7N6XXtPUVKSNw932svGujZ4uWjaybH050QD-xyODeSRQYY0HNMrH6ZkUeL8AALGFJXDYo7dWUfiQ05R8Vz9bCHCD2Cyp5XLhZNTilIneyji0MiMa40DndYiOJkQZrkX49mSPM6VgVFO801zoK9e5Uexp6vZxRzjA3kNtz6rNuQkSbTEIcn57V0cCgTwPDEIC0157NBFGJKuyWJ9TKsii9AG-smXX4yKds2qxSc9iyufFxz26NFnhPUXyap3gToW7PbOs0a7JnMKtbL8mCNywxb6uKL3oNhKHsuXq15d6o2SZBhKjuOO17nwf2tbTxSSxRxxWDsCQGcNohnAYOwRLGOltMAZgTyAlsRsNzO-RUEkP4s3YHMaSQgmRuQxpP94MjwPzbvQfXRa7aUqRfMrVCgyuD1JZPWowBcwHcoYWEW_Dmz2Q2coHrFyT5PXfdGDOW0CHjogN1-qSfsd2zXMlEG7V5YKYDqT4rylm6Dsbios7WvR1aAhmZk2KkDF2Bcdn90B3CLtB6C0y52hiw5ZFlFT-5UKRLZScMmCcpGNfBjRtTBnERSaRc0gSGkF7Mu0Fu6JsJ503UEDNGOq8Dm4NeUgSp6rFm5Wh_0mpS20NDJ-IhEDHHObQcJqqCRcHq5kyilZxUITeqxERfoUNv1xcm8wsyrOB-5Ax6hnaIpYH6_YbigHwL3fhAt4AuXl8POiqIGDPyTJLzMz00zv3yaENtjtC0OZtWp5d4oj9PXPwBjq6NBn0ags6h5cGk7q_MnmGxI-9ph9v5uOkKjXq-NUQcB3vEFhe19lNymqGPSh1cOwroxCMXK6NlrbbPIhOmwF8sKga9A2XZRVr52qDbCa1Iwjzl913pvNMEM4pxCqI3hL_ut40qvDcg6hq5nWk75hNM5z3QNtZQYTN8GBnm-M6KbaMxQFo3dFC8xGptd4-XTpEcvTmLCOCL6EjklH704oLEy2qggRB8XIz7Dcju0urLua3ibjHYKXLclNBge13mVDeUp79yKFBeWUuBr9UyUGAKJwyf0J4JAmEjYk6N304R4NuEfz3ove_pBeZArT9jR5lrr4fW537uzyMwjvjd5Pc0jYit7n68BO5G4OeBbD5W1TBFv9WDLIlWeIkhiI7f1axaMgyx2rahANfylU6I-FMrBYVxPZqZ__a3CJEIfkW9ZoPTsJpuIczXOqpYhduDxBOwk5Bgsv91PqGPlxv92GWQnJLcGBMeWqcclA-zS1QXo7jR3XiDqEq99MvpSp6t0sbYLynzwTdoyCxXEaEs2Mmg-TCUVn7tAWJUnorTnaOacRxp9nRYMwZUOIu3NGHzwL6J549AY7vICubMyrQD5ihDFmLMP8FpWIdcpq0RrboHy9_99xNaENB1Lk55v75hMx9oBtyUvmZYX4YIjMJdK5ZxbtafRqqgYbchFho4Qum4S5PoH8uaaqBDqMt6nZq_vaAszOKUQ5ualKMQse3dFWzTX6MvXm0WBfB0Gmv-FIDnm7EaC4fJWeqZx1udaJlPVaozsdUW_5AFyJJZ_thmSzmmnb34G0LqUMrsYYhne-ANEKT5u6_0BmH6BuWzSdkf_G7b-Q9qtvlad5m17A27MPGy8JZqQ5NKZU4MkRmDGF2IbyQ6loG010v9RCHtgJyeV6wGgcAJTxm53UFNq0rVwv_gTJgFSECikfs1O1-HSJCjqvudsNUOeB2QFg_V_w0OKKajOjvzPpJ9h-7nSJuKAW6udz3tvi5YJfsK0jNHKyMcTXkvCArnIn98R8pEdUGxMz2y5fhNgU5qt4mVd46ePcca4TKNFjekJfLyinaTMmHaOSu9wA9O76obFmzKhlkxAzwmybe2o0Co_CGjFzsK2GkEK3-yhHsPMC7iFWixZm1wlUON9G01eH9T3RkSd-TWtSCCMdbFliD8XAL5PioqEUYJivDpVMhvNiamOzT0QpLcc5fwjpEnEo1xCx1DiTGCfkLx9jVp6pY7Mcw-FRp28LQDK5g-S8BDJIMYdqy0xNZShbEQEBfTDne9-oZiVByE4l1U9D-MAIA0o1SIrVRTHedYCPq0rwc7rI811-A8Bcmd_m6htoa4KVXKIGZQdbuu6fQMKsrPSN3TkV45gUyBNwlfpS0Oe05PakoWQncvp-ByEhbPIZps-TGA98HFJayzz8kVCt-Vduuoq-nIOKExRiaUhx-qkvWRZvFEoPhQasIdVdRB2KQv5GlLh8pFLU_Zqum4yftrxN_WDbe-mNGEXEkwadKCfkX3znY1KHoF030egMYIXoLXVvgwkjyBuRBW-C_9XwfbLJkm0CTeJ3xinQj6ub9dGJxkeOxbR_y4U5ot4-9-PL274NcRgpmxsJ-UqxrNE9lIAK3dkCBmCeB2XSyaH8MzI_x8UABqxuGiRRXDA6ToGkJaUrweOruFJN5Y4i18Z7TH_WyuCtlj6AEbo75AX2MWomSZuiOyyhL-E0hZMkHJvHVz17huwKSpy83Vosv2LP4I3ec9iczQsmzCA4b6NpDROKKu6xMVbiHbiwzSf9E7pdo2_XMAVD23JBgQBhHc_3K90AO5DLOw14KFNtQkLWrLmuyCf5myJwhLBqyIEBz_F5m4I9hMXzlUA7PTspJgQqkQF78yOoKTAGGQPDvr1WiS9MFBudKnscWO8rbuJtBCvBgN4j7ysrzcsYRydrYTY8aSOWUj7th51asFDSZH8Ou_JIRxjrwSVTwoxzs-oqB6Tsc0hxVpItwgR7ioSu1odZGchWU4btEpTltd52GOkMbgjpc31e6ypc5Ud8xfHOJBgO6GIeBwwz_Ol79_CBDEYP4Tp_HvYrQcRgWDwpBt4zXibd24Z6_V1SmXzI-eeOcteXHiRQOoJecB4_XTxn0wc06Grd6Esr4bjfyOohjlLwaOYnXzX3vVoch1aGFwBproGWY9kO-P3JHiPNS23JyYt2_lV-LuU2PFmA8D8YusHnjsMObfj9RKrLUsy2vrBO1B6-TxCOnxSlUS6l_Ql1a9BopRiiLEfp-8Bas2sAkeYAG5TTcioql5exT5cGqnKqae10h2TxikzR8YMPv1mQCcAvsQgg58mAafqCte6yLkrJ_7qFEf1vsoAX-JFND-YbJRVqrlfb3uUgTjPByDX_9mR08auNM_t-6bwwm672uqS5whdgbrakUC2MtTo4ck_-ShEbZ5K1C7s8fSx4TvHNn7Z0h0SWUp3Fehh-_iTIsZxaF-ikAyXUA2eeJBWQ0UZwyOExvjkqmvHVqLLV2WCwTG2eqUspq8aE0lIJQCQYKCXIewi52T_4tiY2-HkElK22dSbOJ-GA0BH-faPrVx4yAWsYcwUnOuRNJvaXA5mUXklVAypt6OBT3ujR6mzxGp2aM5I3n-dtt2aDPxxSpa9IVsPTS-F6hq4SBfboRvd1w7kDp0Zl9dkovNA5bBtIuE7PqBJvTLgsjNYU6J65dt7CXW2ROuUkZEsvk7a5w3hCGxQcahKG4TSDr7LGIdzjJhU_MHOobHkLeyOTIhK5wrzAkpdg3wK4it8-a-13qg8KFTY2ufU8b8W9S8JRtqCoLMHSq01fekdT6nUO-nQLEmEm_Rszti_bUS18LS6Oxp1SmMzkzWB_ykqtpe4-Z2fyvyf6FyAz0qe8JNZfelujUU1F0W5gCY-lX2u7a1SDL9JPgbrUcvVorLSxrwQ-nCEORo5HDRmxgG_j99NlfhhVogWgEziAYmLFaVcBoBL1zCo1I9fTI88iD2ZcCGqbtxnAxIg8cWrrQO29oqLw4x4FXATSNKDlkZKYpvlX28Msc_cpeOJ_SRiP5qg7pegL3x3cTmr9Ah4nSa2mpXAP458Ar6Dp-r9O_nVNL0iQGeoL5PjKg4i18rjhvZW41mPcg9yhamAQsfFo_e87vOfYTl0IkVLmLTetCWux6f8VMhEHYwy01HrvKju77r8AsS2l86Pd7HWHUkUSGbk7r9DdoFTJrJLb7vevF0Df2cJ9-GMYJXlNcJGeQvQxM9KmKD-tX7GdYh8v0-YAMgzfRhdWyF18D2lyuDEx_oWym_bR1OKOt1Szyt0O8NAW--jF4rtwoAq0BJCk-3JamDHOoj1IEJekw2mtJ1AT2iMNjnQjUAYQ3j-CIu8OwwUL54AXsxyTk2_vcoqV_XENNOW-lxe4XbrwKpKOaqOhg0RbpoCs5NQoCYkeswGmg9LUPwa_mwToU8L8FDoQi5XD0ezAbgQntC9Wi40UhMZVnwDAIdM3kPWfPTJHBzhF7RU_WldHTZUo8Vgz6Rj4kOSHc8TLrlgX4WvREA-Ao0f49yJGfiiLj8cl5Mi28GgvUN6t5I8OlTqqe4KKLLcsWKyx526CwUHLuD_euihzs3ZDi5SadzK1GMv1KQ-SZggc_5lEP-msVvy7j7r-0D5KIoyTM6YpbtMlA05ZHfVXiqfTxn3YOFA-i-j9nMOghOgjcEeGGXCc2Kpsp1jmn_tLer5zwUY27O8Jix0MnAA-P40BYTK1eBL4S8uEpeoBanwsaFEPrHJR_5Vv40GsvlT7t3WBiTSS7n680Xv2M_Iz9ARRjt7MdsfOSM22oLXioIivttTg1TlpeukOZB5V1eyPtqFaJ0uw9p-4ZT7zkjTvx1UgxL6B4zEEr7TgOu6PTvGdR8X1Fz4Kx2aWT0vjb2ufVxiNLnsT8mlQMEjJ8VO9jJZ5lcTp_4S0yxdUdOPxv1gQ5YizV0qorkHmrgqDSKkAJjP__9pgC5CyaCkWryx-_8lFUwMZvYHHYS6RVIXvmFtm0_aRdMTNfRtpO0h_e-24XIfLaKXQVfojUCtpxWBhNmUV9FP_plR67qk1brK1qa1wXXQutwn3poH8LFVTJlox55F3wK_h7dc2D1VhwsXBVpNcu4ikcI367NQYbN3mBOKMzSDQxMyFMPKHig3Wd9GToLC_s4-1X6ISY4GCyrxWTkN1fVgqwpGzHEwHOYqEk1m6XXiCNgZ1q6ECLStlxc3l2ndHA0qpceumvxe3Cz8rBthVXKFUhO6fmvatBsWV_-Ou9x0w5Qr5jgu6c_S7dc-CvgUNh6gzSFFiLYgyP40uUSXagC-vxE0b0_tXLsIHfo8dLbvSl96LXN0HSs3vcTZhlbHVqlvDZG6WGJCkjTDDXl5RUVa_7hy7S2oJXZOwySWSVfai6wPYSIenUxmwPbEqe6zXTkA4wDVwp-EYtPtYYffkX7btBfUy7Z_M4rjZs9M3XnFxIFtpVRVNmPMvmodDDiu8DRmORZNTCd8tGGXgbMm15Q0kpE797wzrn5qxB8inUI66nxBvhAXVQnFRutrZy-W_-2uyA6jwna1i4AwYX8QKb6w1DLTWQcY4zDTWBiEB2RSDaK9ac7jO8XiWXB67SHFPRDJrz4zUlJKxO1BTWZnrobNpIrOHNonq1yfHTu8IWoq3H2-oRH17f2Vgz-JChGd5Te3_sFy4eoaHJA4g0ZVvDSK_0qUw0GKD0S3rRiqfjbxWKRR0PFw2LeNeZoCElqs5gGxbbj1RPmqANG2jnWVpwXf4eBJh35lfpvpfNC6d4lbvPxYpZ8LsV0O6HFSiQAKRJVhcVZkb19G67yYubLIs79-CHbnDdsKtI2YdIBdXuvgiw7V4bdxTqHzLEbQCsuU5MprTCQhU-a4TDcHu2ao5KV_Zt-loAvYRMJZwBtlU7-NteW7GVfhwZRHewJptrlXk45OkyX7_KNGy5ma3ylLXHH7aD_G_4j1_PDRpENw24SLyEAvkgnoDzbnJfa1NH5-fNkKrSC98RD3w5JW-6ONbrXL_L7xxqTkF69Q3t4YjIcgdpQW3j7yYUI1K_LzhRLhDRAVdH1xzwFQdwUBuf63R6zSPuE999f7Wn8xN00I1pYCjonUJkN8meUykYv_Mo34NKk65vFSfoEDdUEh5Q-BHkDvH8CCN3VDYjxjxAPSq7CY7Trg7X9dS9TQ1I3kB18uigANDnpqeM_TuHwOFIdb435R1aeQZQANk5GapqcE8PMrjoTf1M1wP3UxW46X32DbFytlgcLxIK9D-CMiNFVjqghVjOKz3WM4wEFc0TMV6pJeLSJLrvncHAJX6oibQ59S5xgx5GDqf5oO14zSO23dv8EE4ulBce7O_8wZybwSOW1K1lRN3AnWCQ70DCW7KDflEFzA43hDSAHNsccoCCWnLu-JO5h8hg5IwjwwZzKB569dw6CeMkxqIUHDKRVkD4DwB3urEuC1H6N78Za2quY8PPXrnoPrFUbNWYQ-HmS-s3-BLRXQEoaaetCMnq67N8IewpXIJr-x6FHwaGdPCcG0TDMR_kRvWyjy0kUNjnyL4cW2zPzpIL11PPV013RqMcO_XfEYrC16iNVdovOl3VPc781a8453eFq9uvMg2tVnGK05106DhavU45DBWzsBm2k63NmUBcuwYQf4y0gyEEPY-OurLDnoZUP7VCv8jeYwv-VL8jOWenMsnzWcJxlqjgVyQjwl3scBQ9VxPCR3N8MwAwtsdMLxh"
                    }
                  ]
                }
              }
            ],
            "usage": {
              "prompt_tokens": 2407,
              "completion_tokens": 1066,
              "total_tokens": 3473,
              "completion_tokens_details": {
                "reasoning_tokens": 1029
              }
            }
          }
        },
        "score": 0.0,
        "ground_truth": {
          "diagnosis": "Neurofibromatosis type 1",
          "assay": "3D microtissue viability",
          "tumorType": "Malignant Peripheral Nerve Sheath Tumor"
        },
        "token_usage": {
          "input_tokens": 2407,
          "output_tokens": 1066,
          "total_tokens": 3473
        },
        "tool_calls": [],
        "tool_execution_history": []
      }
    ],
    "metrics": {
      "total_samples": 10,
      "successful_runs": 10,
      "failed_runs": 0,
      "success_rate": 1.0,
      "average_score": 0.4,
      "min_score": 0.0,
      "max_score": 1.0,
      "num_scored": 10
    },
    "duration_seconds": 126.47742223739624,
    "token_usage": {
      "input_tokens": 24030,
      "output_tokens": 5987,
      "total_tokens": 30017
    }
  }
}